Loading...

Kenneth Feingold, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentMedicine
AddressVAMC 2
San Francisco CA 94121
Phone415-750-2005
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidencySchool of Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    PPARs and LXR Regulate Epidermal Differentiation
    NIH/NIAMS R01AR050629Aug 9, 2004 - May 31, 2008
    Role: Principal Investigator
    Effects of Psychological Stress on the Stratum Corneum
    NIH/NIAMS R01AR049932Apr 1, 2004 - Dec 31, 2009
    Role: Principal Investigator
    Stratum Corneum Acidification in the Neonate
    NIH/NICHD R01HD029706May 15, 1994 - Apr 30, 2010
    Role: Principal Investigator
    REGULATION OF EPIDERMAL LIPID METABOLISM
    NIH/NIAMS R01AR039639Jan 10, 1991 - Jun 30, 2001
    Role: Principal Investigator
    Relationship of Keratinocyte Function to Differentiation
    NIH/NIAMS P01AR039448Jul 15, 1988 - Jul 31, 2010
    Role: Co-Investigator
    CHOLESTEROL SYNTHESIS IN DIABETIC ANIMALS
    NIH/NIADDK R01AM032685Jul 1, 1983 - Jun 30, 1986
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Gupta N, Feingold K, Dhaliwal G. Stressing Signal Versus Noise: An Exercise in Clinical Reasoning. J Gen Intern Med. 2016 Oct 31. PMID: 27798784.
      View in: PubMed
    2. Feingold K, Grunfeld C. Effect of inflammation on HDL structure and function. Curr Opin Lipidol. 2016 Oct; 27(5):521-30. PMID: 27495134.
      View in: PubMed
    3. Brondfield S, Feingold K. Symptomatic Graves' Disease After Autoimmune Hypothyroidism. Am J Med. 2016 May; 129(5):e19-20. PMID: 26772649.
      View in: PubMed
    4. Duprez DA, Otvos J, Tracy RP, Feingold K, Greenland P, Gross MD, Lima JA, Mackey RH, Neaton JD, Sanchez OA, Jacobs DR. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2015 Sep; 4(9):e002295. PMID: 26370448; PMCID: PMC4599511.
    5. Feingold K. TLR3: a receptor that recognizes cell injury is essential for permeability barrier homeostasis following UV irradiation. J Invest Dermatol. 2015 Feb; 135(2):339-40. PMID: 25573047.
      View in: PubMed
    6. Feingold K. Statin myopathy: a problem looking for a solution. Atherosclerosis. 2015 Mar; 239(1):85-6. PMID: 25576849.
      View in: PubMed
    7. Sun R, Celli A, Crumrine D, Hupe M, Adame LC, Pennypacker SD, Park K, Uchida Y, Feingold K, Elias PM, Ilic D, Mauro TM. Lowered humidity produces human epidermal equivalents with enhanced barrier properties. Tissue Eng Part C Methods. 2015 Jan; 21(1):15-22. PMID: 24803151; PMCID: PMC4291214 [Available on 01/01/16].
    8. Feingold K, Moser A, Shigenaga JK, Grunfeld C. Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages. J Lipid Res. 2014 Dec; 55(12):2501-8. PMID: 25320346; PMCID: PMC4242443 [Available on 12/01/15].
    9. Lin TK, Man MQ, Santiago JL, Scharschmidt TC, Hupe M, Martin-Ezquerra G, Youm JK, Zhai Y, Trullas C, Feingold K, Elias PM. Paradoxical benefits of psychological stress in inflammatory dermatoses models are glucocorticoid mediated. J Invest Dermatol. 2014 Dec; 134(12):2890-7. PMID: 24991965; PMCID: PMC4227540.
    10. Man MQ, Lin TK, Santiago JL, Celli A, Zhong L, Huang ZM, Roelandt T, Hupe M, Sundberg JP, Silva KA, Crumrine D, Martin-Ezquerra G, Trullas C, Sun R, Wakefield JS, Wei ML, Feingold K, Mauro TM, Elias PM. Basis for enhanced barrier function of pigmented skin. J Invest Dermatol. 2014 Sep; 134(9):2399-407. PMID: 24732399; PMCID: PMC4134407.
    11. Feingold K. The adverse effect of IFN gamma on stratum corneum structure and function in psoriasis and atopic dermatitis. J Invest Dermatol. 2014 Mar; 134(3):597-600. PMID: 24518112.
      View in: PubMed
    12. Feingold K, Elias P. The important role of lipids in the epidermis and their role in the formation and maintenance of the cutaneous barrier. Biochim Biophys Acta. 2014 Mar; 1841(3):279. PMID: 24564908.
      View in: PubMed
    13. Feingold K. Capsule commentary on Radin, pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med. 2014 Feb; 29(2):363. PMID: 24065382; PMCID: PMC3912282.
    14. Elias PM, Williams ML, Choi EH, Feingold K. Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis. Biochim Biophys Acta. 2014 Mar; 1841(3):353-61. PMID: 24291327; PMCID: PMC3966299.
    15. Feingold K, Elias PM. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta. 2014 Mar; 1841(3):280-94. PMID: 24262790.
      View in: PubMed
    16. Yau RK, Strotmeyer ES, Resnick HE, Sellmeyer DE, Feingold K, Cauley JA, Vittinghoff E, De Rekeneire N, Harris TB, Nevitt MC, Cummings SR, Shorr RI, Schwartz AV. Diabetes and risk of hospitalized fall injury among older adults. Diabetes Care. 2013 Dec; 36(12):3985-91. PMID: 24130352; PMCID: PMC3836123.
    17. Feingold K. Innate immunity stimulates permeability barrier homeostasis. J Invest Dermatol. 2013 Aug; 133(8):1925-7. PMID: 23856931.
      View in: PubMed
    18. Jiang YJ, Kim P, Uchida Y, Elias PM, Bikle DD, Grunfeld C, Feingold K. Ceramides stimulate caspase-14 expression in human keratinocytes. Exp Dermatol. 2013 Feb; 22(2):113-8. PMID: 23362869; PMCID: PMC4099380.
    19. Feingold K, Grunfeld C. Lipids: a key player in the battle between the host and microorganisms. J Lipid Res. 2012 Dec; 53(12):2487-9. PMID: 23075464; PMCID: PMC3494250.
    20. Lin TK, Man MQ, Santiago JL, Park K, Roelandt T, Oda Y, Hupe M, Crumrine D, Lee HJ, Gschwandtner M, Thyssen JP, Trullas C, Tschachler E, Feingold K, Elias PM. Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function. J Invest Dermatol. 2013 Feb; 133(2):469-78. PMID: 23014339; PMCID: PMC3532566.
    21. Celli A, Zhai Y, Jiang YJ, Crumrine D, Elias PM, Feingold K, Mauro TM. Tight junction properties change during epidermis development. Exp Dermatol. 2012 Oct; 21(10):798-801. PMID: 22882565; PMCID: PMC3477265.
    22. Feingold K. Lamellar bodies: the key to cutaneous barrier function. J Invest Dermatol. 2012 Aug; 132(8):1951-3. PMID: 22797297.
      View in: PubMed
    23. Feingold K, Shigenaga JK, Kazemi MR, McDonald CM, Patzek SM, Cross AS, Moser A, Grunfeld C. Mechanisms of triglyceride accumulation in activated macrophages. J Leukoc Biol. 2012 Oct; 92(4):829-39. PMID: 22753953; PMCID: PMC3441312.
    24. Feingold K, Grunfeld C. Psoriasis: it's more than just the skin. J Lipid Res. 2012 Aug; 53(8):1427-9. PMID: 22685321; PMCID: PMC3540839.
    25. Elias PM, Williams ML, Feingold K. Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders. Clin Dermatol. 2012 May-Jun; 30(3):311-22. PMID: 22507046; PMCID: PMC3607361.
    26. Feingold K, Denda M. Regulation of permeability barrier homeostasis. Clin Dermatol. 2012 May-Jun; 30(3):263-8. PMID: 22507038.
      View in: PubMed
    27. Feingold K, Shigenaga JK, Cross AS, Moser A, Grunfeld C. Angiopoietin like protein 4 expression is decreased in activated macrophages. Biochem Biophys Res Commun. 2012 May 11; 421(3):612-5. PMID: 22538368.
      View in: PubMed
    28. Feingold K, Grunfeld C, Heuer JG, Gupta A, Cramer M, Zhang T, Shigenaga JK, Patzek SM, Chan ZW, Moser A, Bina H, Kharitonenkov A. FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis. Endocrinology. 2012 Jun; 153(6):2689-700. PMID: 22474187; PMCID: PMC3359613.
    29. Man W, Man M, Hupe M, Martin-Ezquerra G, Feingold K, Elias PM, Man MQ. Topical herbal extract (Huangdang mixture) exhibits both preventive and therapeutic effects in murine acute irritant contact dermatitis. Int J Dermatol. 2011 Nov; 50(11):1421-7. PMID: 22004502.
      View in: PubMed
    30. Lu B, Xu FY, Taylor WA, Feingold K, Hatch GM. Cardiolipin synthase-1 mRNA expression does not correlate with endogenous cardiolipin synthase enzyme activity in vitro and in vivo in mammalian lipopolysaccharide models of inflammation. Inflammation. 2011 Aug; 34(4):247-54. PMID: 20652826.
      View in: PubMed
    31. Feingold K, Moser A, Shigenaga JK, Grunfeld C. Inflammation inhibits GPR81 expression in adipose tissue. Inflamm Res. 2011 Oct; 60(10):991-5. PMID: 21751047.
      View in: PubMed
    32. Hatano Y, Elias PM, Crumrine D, Feingold K, Katagiri K, Fujiwara S. Efficacy of combined peroxisome proliferator-activated receptor-a ligand and glucocorticoid therapy in a murine model of atopic dermatitis. J Invest Dermatol. 2011 Sep; 131(9):1845-52. PMID: 21633371; PMCID: PMC3156961.
    33. Jiang YJ, Kim P, Lu YF, Feingold K. PPARgamma activators stimulate aquaporin 3 expression in keratinocytes/epidermis. Exp Dermatol. 2011 Jul; 20(7):595-9. PMID: 21457357; PMCID: PMC3120929.
    34. Feingold K, Jiang YJ. The mechanisms by which lipids coordinately regulate the formation of the protein and lipid domains of the stratum corneum: Role of fatty acids, oxysterols, cholesterol sulfate and ceramides as signaling molecules. Dermatoendocrinol. 2011 Apr; 3(2):113-8. PMID: 21695021; PMCID: PMC3117011.
    35. Feingold K. Lipid metabolism in the epidermis. Dermatoendocrinol. 2011 Apr; 3(2):52. PMID: 21695011; PMCID: PMC3117001.
    36. Jiang YJ, Feingold K. The expression and regulation of enzymes mediating the biosynthesis of triglycerides and phospholipids in keratinocytes/epidermis. Dermatoendocrinol. 2011 Apr; 3(2):70-6. PMID: 21695015; PMCID: PMC3117005.
    37. Feingold K, Moser A, Shigenaga JK, Grunfeld C. Inflammation inhibits the expression of phosphoenolpyruvate carboxykinase in liver and adipose tissue. Innate Immun. 2012 Apr; 18(2):231-40. PMID: 21450790.
      View in: PubMed
    38. Man M, Hupe M, Mackenzie D, Kim H, Oda Y, Crumrine D, Lee SH, Martin-Ezquerra G, Trullas C, Mauro TM, Feingold K, Elias PM, Man MQ. A topical Chinese herbal mixture improves epidermal permeability barrier function in normal murine skin. Exp Dermatol. 2011 Mar; 20(3):285-8. PMID: 21323748; PMCID: PMC4548955.
    39. Feingold K, Grunfeld C. The role of HDL in innate immunity. J Lipid Res. 2011 Jan; 52(1):1-3. PMID: 20944062; PMCID: PMC2999920.
    40. Lu B, Jiang YJ, Kim P, Moser A, Elias PM, Grunfeld C, Feingold K. Expression and regulation of GPAT isoforms in cultured human keratinocytes and rodent epidermis. J Lipid Res. 2010 Nov; 51(11):3207-16. PMID: 20719759; PMCID: PMC2952561.
    41. Jiang YJ, Lu B, Tarling EJ, Kim P, Man MQ, Crumrine D, Edwards PA, Elias PM, Feingold K. Regulation of ABCG1 expression in human keratinocytes and murine epidermis. J Lipid Res. 2010 Nov; 51(11):3185-95. PMID: 20675829; PMCID: PMC2952559.
    42. Jiang YJ, Lu B, Crumrine D, Elias PM, Feingold K. IL-6 stimulates but is not essential for stratum corneum formation and permeability barrier development during gestation. Exp Dermatol. 2010 Aug; 19(8):e31-6. PMID: 19758319.
      View in: PubMed
    43. Fluhr JW, Elias PM, Man MQ, Hupe M, Selden C, Sundberg JP, Tschachler E, Eckhart L, Mauro TM, Feingold K. Is the filaggrin-histidine-urocanic acid pathway essential for stratum corneum acidification? J Invest Dermatol. 2010 Aug; 130(8):2141-4. PMID: 20376063; PMCID: PMC4548931.
    44. Feingold K, Shigenaga JK, Patzek SM, Chui LG, Moser A, Grunfeld C. Endotoxin, zymosan, and cytokines decrease the expression of the transcription factor, carbohydrate response element binding protein, and its target genes. Innate Immun. 2011 Apr; 17(2):174-82. PMID: 20100709.
      View in: PubMed
    45. Feingold K, Grunfeld C. The acute phase response inhibits reverse cholesterol transport. J Lipid Res. 2010 Apr; 51(4):682-4. PMID: 20071695; PMCID: PMC2842157.
    46. Lu B, Moser A, Shigenaga JK, Grunfeld C, Feingold K. The acute phase response stimulates the expression of angiopoietin like protein 4. Biochem Biophys Res Commun. 2010 Jan 22; 391(4):1737-41. PMID: 20043872.
      View in: PubMed
    47. Feingold K. Does inhibition of apolipoprotein B synthesis produce foie gras? J Lipid Res. 2010 May; 51(5):877-8. PMID: 20042543; PMCID: PMC2853454.
    48. Hatano Y, Man MQ, Uchida Y, Crumrine D, Mauro TM, Feingold K, Elias PM, Holleran WM. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. J Allergy Clin Immunol. 2010 Jan; 125(1):160-9.e1-5. PMID: 19818482; PMCID: PMC2859962.
    49. Hachem JP, Roelandt T, Schürer N, Pu X, Fluhr J, Giddelo C, Man MQ, Crumrine D, Roseeuw D, Feingold K, Mauro T, Elias PM. Acute acidification of stratum corneum membrane domains using polyhydroxyl acids improves lipid processing and inhibits degradation of corneodesmosomes. J Invest Dermatol. 2010 Feb; 130(2):500-10. PMID: 19741713; PMCID: PMC2844116.
    50. Feingold K, Kazemi MR, Magra AL, McDonald CM, Chui LG, Shigenaga JK, Patzek SM, Chan ZW, Londos C, Grunfeld C. ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists. Atherosclerosis. 2010 Mar; 209(1):81-8. PMID: 19748622.
      View in: PubMed
    51. Scharschmidt TC, Man MQ, Hatano Y, Crumrine D, Gunathilake R, Sundberg JP, Silva KA, Mauro TM, Hupe M, Cho S, Wu Y, Celli A, Schmuth M, Feingold K, Elias PM. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol. 2009 Sep; 124(3):496-506, 506.e1-6. PMID: 19733297; PMCID: PMC2881668.
    52. Jiang YJ, Barish G, Lu B, Evans RM, Crumrine D, Schmuth M, Elias PM, Feingold K. PPARd activation promotes stratum corneum formation and epidermal permeability barrier development during late gestation. J Invest Dermatol. 2010 Feb; 130(2):511-9. PMID: 19675577.
      View in: PubMed
    53. Man MQ, Xin SJ, Song SP, Cho SY, Zhang XJ, Tu CX, Feingold K, Elias PM. Variation of skin surface pH, sebum content and stratum corneum hydration with age and gender in a large Chinese population. Skin Pharmacol Physiol. 2009; 22(4):190-9. PMID: 19648780; PMCID: PMC2836947.
    54. Song SP, Elias PM, Lv CZ, Shi YJ, Guang P, Zhang XJ, Feingold K, Man MQ. Decreased cutaneous resonance running time in cured leprosy subjects. Skin Pharmacol Physiol. 2009; 22(4):218-24. PMID: 19648783; PMCID: PMC2836948.
    55. Feingold K, Moser A, Patzek SM, Shigenaga JK, Grunfeld C. Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm. J Lipid Res. 2009 Oct; 50(10):2055-63. PMID: 19443862; PMCID: PMC2739760.
    56. Jiang YJ, Uchida Y, Lu B, Kim P, Mao C, Akiyama M, Elias PM, Holleran WM, Grunfeld C, Feingold K. Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor {delta} in human keratinocytes. J Biol Chem. 2009 Jul 10; 284(28):18942-52. PMID: 19429679; PMCID: PMC2707228.
    57. Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold K, Resnick HE, Tylavsky FA, Black DM, Cummings SR, Harris TB, Bauer DC. Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab. 2009 Jul; 94(7):2380-6. PMID: 19383780; PMCID: PMC2708944.
    58. Man M, Elias PM, Man W, Wu Y, Bourguignon LY, Feingold K, Man MQ. The role of CD44 in cutaneous inflammation. Exp Dermatol. 2009 Nov; 18(11):962-8. PMID: 19469887; PMCID: PMC2784008.
    59. Demerjian M, Choi EH, Man MQ, Chang S, Elias PM, Feingold K. Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis. Exp Dermatol. 2009 Jul; 18(7):643-9. PMID: 19236478; PMCID: PMC2704255.
    60. Jiang YJ, Lu B, Crumrine D, Man MQ, Elias PM, Feingold K. IL-1alpha accelerates stratum corneum formation and improves permeability barrier homeostasis during murine fetal development. J Dermatol Sci. 2009 May; 54(2):88-98. PMID: 19216058.
      View in: PubMed
    61. Hatano Y, Man MQ, Uchida Y, Crumrine D, Scharschmidt TC, Kim EG, Mauro TM, Feingold K, Elias PM, Holleran WM. Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis. J Invest Dermatol. 2009 Jul; 129(7):1824-35. PMID: 19177139; PMCID: PMC2695850.
    62. Gunathilake R, Schurer NY, Shoo BA, Celli A, Hachem JP, Crumrine D, Sirimanna G, Feingold K, Mauro TM, Elias PM. pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. J Invest Dermatol. 2009 Jul; 129(7):1719-29. PMID: 19177137; PMCID: PMC2695842.
    63. Song SP, Lv CZ, Feingold K, Hou QN, Li ZY, Guo CY, Elias PM, Man MQ. Abnormalities in stratum corneum function in patients recovered from leprosy. Skin Pharmacol Physiol. 2009; 22(3):131-6. PMID: 19136834; PMCID: PMC2790797.
    64. Roelandt T, Giddelo C, Heughebaert C, Denecker G, Hupe M, Crumrine D, Kusuma A, Haftek M, Roseeuw D, Declercq W, Feingold K, Elias PM, Hachem JP. The "caveolae brake hypothesis" and the epidermal barrier. J Invest Dermatol. 2009 Apr; 129(4):927-36. PMID: 19005485.
      View in: PubMed
    65. Feingold K. The outer frontier: the importance of lipid metabolism in the skin. J Lipid Res. 2009 Apr; 50 Suppl:S417-22. PMID: 18980941; PMCID: PMC2674689.
    66. Grunfeld C, Feingold K. Endotoxin in the gut and chylomicrons: translocation or transportation? J Lipid Res. 2009 Jan; 50(1):1-2. PMID: 18957696.
      View in: PubMed
    67. Lu B, Lu Y, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab. 2008 Dec; 295(6):E1502-9. PMID: 18940942; PMCID: PMC2603550.
    68. Fluhr JW, Man MQ, Hachem JP, Crumrine D, Mauro TM, Elias PM, Feingold K. Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification. J Invest Dermatol. 2009 Feb; 129(2):365-74. PMID: 18704104; PMCID: PMC4548956.
    69. Elias PM, Arbiser J, Brown BE, Rossiter H, Man MQ, Cerimele F, Crumrine D, Gunathilake R, Choi EH, Uchida Y, Tschachler E, Feingold K. Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. Am J Pathol. 2008 Sep; 173(3):689-99. PMID: 18688025; PMCID: PMC2527083.
    70. Feingold K, Moser AH, Shigenaga JK, Patzek SM, Grunfeld C. Inflammation stimulates the expression of PCSK9. Biochem Biophys Res Commun. 2008 Sep 19; 374(2):341-4. PMID: 18638454; PMCID: PMC2571081.
    71. Feingold K, Wang Y, Moser A, Shigenaga JK, Grunfeld C. LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney. J Lipid Res. 2008 Oct; 49(10):2179-87. PMID: 18574256; PMCID: PMC2533407.
    72. Slominski A, Wortsman J, Paus R, Elias PM, Tobin DJ, Feingold K. Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech. 2008 Jun 1; 5(2):137-144. PMID: 19492070.
      View in: PubMed
    73. Grunfeld C, Feingold K. HDL and innate immunity: a tale of two apolipoproteins. J Lipid Res. 2008 Aug; 49(8):1605-6. PMID: 18515886.
      View in: PubMed
    74. Man MQ, Shi Y, Man M, Lee SH, Demerjian M, Chang S, Feingold K, Elias PM. Chinese herbal medicine (Tuhuai extract) exhibits topical anti-proliferative and anti-inflammatory activity in murine disease models. Exp Dermatol. 2008 Aug; 17(8):681-7. PMID: 18341576; PMCID: PMC2843409.
    75. Schmuth M, Jiang YJ, Dubrac S, Elias PM, Feingold K. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res. 2008 Mar; 49(3):499-509. PMID: 18182682.
      View in: PubMed
    76. Demerjian M, Hachem JP, Tschachler E, Denecker G, Declercq W, Vandenabeele P, Mauro T, Hupe M, Crumrine D, Roelandt T, Houben E, Elias PM, Feingold K. Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol. 2008 Jan; 172(1):86-97. PMID: 18156206; PMCID: PMC2189608.
    77. Schwartz AV, Vittinghoff E, Sellmeyer DE, Feingold K, de Rekeneire N, Strotmeyer ES, Shorr RI, Vinik AI, Odden MC, Park SW, Faulkner KA, Harris TB. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care. 2008 Mar; 31(3):391-6. PMID: 18056893; PMCID: PMC2288549.
    78. Feingold K, Shigenaga JK, Chui LG, Moser A, Khovidhunkit W, Grunfeld C. Infection and inflammation decrease apolipoprotein M expression. Atherosclerosis. 2008 Jul; 199(1):19-26. PMID: 18054359.
      View in: PubMed
    79. Aberg KM, Radek KA, Choi EH, Kim DK, Demerjian M, Hupe M, Kerbleski J, Gallo RL, Ganz T, Mauro T, Feingold K, Elias PM. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest. 2007 Nov; 117(11):3339-49. PMID: 17975669; PMCID: PMC2045593.
    80. Aberg KM, Man MQ, Gallo RL, Ganz T, Crumrine D, Brown BE, Choi EH, Kim DK, Schröder JM, Feingold K, Elias PM. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol. 2008 Apr; 128(4):917-25. PMID: 17943185; PMCID: PMC2671223.
    81. Denda M, Tsutsumi M, Inoue K, Crumrine D, Feingold K, Elias PM. Potassium channel openers accelerate epidermal barrier recovery. Br J Dermatol. 2007 Nov; 157(5):888-93. PMID: 17916210.
      View in: PubMed
    82. Feingold K. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res. 2007 Dec; 48(12):2531-46. PMID: 17872588.
      View in: PubMed
    83. Man MQ, Barish GD, Schmuth M, Crumrine D, Barak Y, Chang S, Jiang Y, Evans RM, Elias PM, Feingold K. Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol. 2008 Feb; 128(2):370-7. PMID: 17713572.
      View in: PubMed
    84. Man MQ, Hatano Y, Lee SH, Man M, Chang S, Feingold K, Leung DY, Holleran W, Uchida Y, Elias PM. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol. 2008 Jan; 128(1):79-86. PMID: 17671515; PMCID: PMC2671229.
    85. Jiang YJ, Lu B, Kim P, Paragh G, Schmitz G, Elias PM, Feingold K. PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. J Invest Dermatol. 2008 Jan; 128(1):104-9. PMID: 17611579.
      View in: PubMed
    86. Feingold K, Schmuth M, Elias PM. The regulation of permeability barrier homeostasis. J Invest Dermatol. 2007 Jul; 127(7):1574-6. PMID: 17568800.
      View in: PubMed
    87. Choi EH, Man MQ, Xu P, Xin S, Liu Z, Crumrine DA, Jiang YJ, Fluhr JW, Feingold K, Elias PM, Mauro TM. Stratum corneum acidification is impaired in moderately aged human and murine skin. J Invest Dermatol. 2007 Dec; 127(12):2847-56. PMID: 17554364.
      View in: PubMed
    88. Ilic D, Mao-Qiang M, Crumrine D, Dolganov G, Larocque N, Xu P, Demerjian M, Brown BE, Lim ST, Ossovskaya V, Schlaepfer DD, Fisher SJ, Feingold K, Elias PM, Mauro TM. Focal adhesion kinase controls pH-dependent epidermal barrier homeostasis by regulating actin-directed Na+/H+ exchanger 1 plasma membrane localization. Am J Pathol. 2007 Jun; 170(6):2055-67. PMID: 17525272; PMCID: PMC1899430.
    89. Lu B, Sims PJ, Wiedmer T, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response. Biochim Biophys Acta. 2007 Sep; 1771(9):1177-85. PMID: 17590392.
      View in: PubMed
    90. Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C, Feingold K. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Metabolism. 2007 Feb; 56(2):267-79. PMID: 17224343; PMCID: PMC2700944.
    91. Van Q, Liu J, Lu B, Feingold K, Shi Y, Lee RM, Hatch GM. Phospholipid scramblase-3 regulates cardiolipin de novo biosynthesis and its resynthesis in growing HeLa cells. Biochem J. 2007 Jan 1; 401(1):103-9. PMID: 16939411; PMCID: PMC1698660.
    92. Staprans I, Pan XM, Rapp JH, Moser AH, Feingold K. Ezetimibe inhibits the incorporation of dietary oxidized cholesterol into lipoproteins. J Lipid Res. 2006 Nov; 47(11):2575-80. PMID: 16894239.
      View in: PubMed
    93. Choi EH, Demerjian M, Crumrine D, Brown BE, Mauro T, Elias PM, Feingold K. Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function. Am J Physiol Regul Integr Comp Physiol. 2006 Dec; 291(6):R1657-62. PMID: 16857896.
      View in: PubMed
    94. Lu B, Moser AH, Shigenaga JK, Feingold K, Grunfeld C. Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response. J Lipid Res. 2006 Oct; 47(10):2179-90. PMID: 16847310.
      View in: PubMed
    95. Jiang YJ, Lu B, Kim P, Elias PM, Feingold K. Regulation of ABCA1 expression in human keratinocytes and murine epidermis. J Lipid Res. 2006 Oct; 47(10):2248-58. PMID: 16825673.
      View in: PubMed
    96. Fluhr JW, Feingold K, Elias PM. Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models. Exp Dermatol. 2006 Jul; 15(7):483-92. PMID: 16761956.
      View in: PubMed
    97. Bourguignon LY, Ramez M, Gilad E, Singleton PA, Man MQ, Crumrine DA, Elias PM, Feingold K. Hyaluronan-CD44 interaction stimulates keratinocyte differentiation, lamellar body formation/secretion, and permeability barrier homeostasis. J Invest Dermatol. 2006 Jun; 126(6):1356-65. PMID: 16557236.
      View in: PubMed
    98. Hachem JP, Houben E, Crumrine D, Man MQ, Schurer N, Roelandt T, Choi EH, Uchida Y, Brown BE, Feingold K, Elias PM. Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol. 2006 Sep; 126(9):2074-86. PMID: 16691196.
      View in: PubMed
    99. Wu Q, Ortegon AM, Tsang B, Doege H, Feingold K, Stahl A. FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol. 2006 May; 26(9):3455-67. PMID: 16611988; PMCID: PMC1447434.
    100. Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka-Czernik B, Feingold K, Strotmeyer ES, Resnick HE, Carbone L, Beamer BA, Park SW, Lane NE, Harris TB, Cummings SR. Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab. 2006 Sep; 91(9):3349-54. PMID: 16608888; PMCID: PMC1563497.
    101. Hachem JP, Wagberg F, Schmuth M, Crumrine D, Lissens W, Jayakumar A, Houben E, Mauro TM, Leonardsson G, Brattsand M, Egelrud T, Roseeuw D, Clayman GL, Feingold K, Williams ML, Elias PM. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol. 2006 Jul; 126(7):1609-21. PMID: 16601670.
      View in: PubMed
    102. Lu B, Xu FY, Jiang YJ, Choy PC, Hatch GM, Grunfeld C, Feingold K. Cloning and characterization of a cDNA encoding human cardiolipin synthase (hCLS1). J Lipid Res. 2006 Jun; 47(6):1140-5. PMID: 16547353.
      View in: PubMed
    103. Demerjian M, Man MQ, Choi EH, Brown BE, Crumrine D, Chang S, Mauro T, Elias PM, Feingold K. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model. Exp Dermatol. 2006 Mar; 15(3):154-60. PMID: 16480422.
      View in: PubMed
    104. Man MQ, Choi EH, Schmuth M, Crumrine D, Uchida Y, Elias PM, Holleran WM, Feingold K. Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing. J Invest Dermatol. 2006 Feb; 126(2):386-92. PMID: 16374473.
      View in: PubMed
    105. Sweeney TR, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy. Am J Physiol Endocrinol Metab. 2006 Jun; 290(6):E1313-20. PMID: 16434558.
      View in: PubMed
    106. Schmuth M, Ortegon AM, Mao-Qiang M, Elias PM, Feingold K, Stahl A. Differential expression of fatty acid transport proteins in epidermis and skin appendages. J Invest Dermatol. 2005 Dec; 125(6):1174-81. PMID: 16354187.
      View in: PubMed
    107. Fluhr JW, Crumrine D, Mao-Qiang M, Moskowitz DG, Elias PM, Feingold K. Topical liver x receptor activators accelerate postnatal acidification of stratum corneum and improve function in the neonate. J Invest Dermatol. 2005 Dec; 125(6):1206-14. PMID: 16354191.
      View in: PubMed
    108. Staprans I, Pan XM, Rapp JH, Feingold K. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. Mol Nutr Food Res. 2005 Nov; 49(11):1075-82. PMID: 16270280.
      View in: PubMed
    109. Hachem JP, Behne M, Aronchik I, Demerjian M, Feingold K, Elias PM, Mauro TM. Extracellular pH Controls NHE1 expression in epidermis and keratinocytes: implications for barrier repair. J Invest Dermatol. 2005 Oct; 125(4):790-7. PMID: 16185280.
      View in: PubMed
    110. Lu B, Jiang YJ, Man MQ, Brown B, Elias PM, Feingold K. Expression and regulation of 1-acyl-sn-glycerol- 3-phosphate acyltransferases in the epidermis. J Lipid Res. 2005 Nov; 46(11):2448-57. PMID: 16150824.
      View in: PubMed
    111. Jiang YJ, Kim P, Elias PM, Feingold K. LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes. J Lipid Res. 2005 Dec; 46(12):2657-66. PMID: 16150827.
      View in: PubMed
    112. Hachem JP, Man MQ, Crumrine D, Uchida Y, Brown BE, Rogiers V, Roseeuw D, Feingold K, Elias PM. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol. 2005 Sep; 125(3):510-20. PMID: 16117792.
      View in: PubMed
    113. Wang Y, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. J Lipid Res. 2005 Nov; 46(11):2377-87. PMID: 16106051.
      View in: PubMed
    114. Choi EH, Man MQ, Wang F, Zhang X, Brown BE, Feingold K, Elias PM. Is endogenous glycerol a determinant of stratum corneum hydration in humans? J Invest Dermatol. 2005 Aug; 125(2):288-93. PMID: 16098039.
      View in: PubMed
    115. Kim MS, Shigenaga JK, Moser AH, Feingold K, Grunfeld C. Suppression of estrogen-related receptor alpha and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response. J Lipid Res. 2005 Oct; 46(10):2282-8. PMID: 16061943.
      View in: PubMed
    116. Choi EH, Brown BE, Crumrine D, Chang S, Man MQ, Elias PM, Feingold K. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol. 2005 Mar; 124(3):587-95. PMID: 15737200.
      View in: PubMed
    117. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold K. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol. 2005 Jun; 25(6):1220-4. PMID: 15705927.
      View in: PubMed
    118. Khovidhunkit W, Hachem JP, Medzihradszky KF, Duchateau PN, Shigenaga JK, Moser AH, Movsesyan I, Naya-Vigne J, Kane JP, Feingold K, Grunfeld C. Parotid secretory protein is an HDL-associated protein with anticandidal activity. Am J Physiol Regul Integr Comp Physiol. 2005 May; 288(5):R1306-15. PMID: 15637169.
      View in: PubMed
    119. Schwartz AV, Sellmeyer DE, Strotmeyer ES, Tylavsky FA, Feingold K, Resnick HE, Shorr RI, Nevitt MC, Black DM, Cauley JA, Cummings SR, Harris TB. Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res. 2005 Apr; 20(4):596-603. PMID: 15765178.
      View in: PubMed
    120. Khovidhunkit W, Duchateau PN, Medzihradszky KF, Moser AH, Naya-Vigne J, Shigenaga JK, Kane JP, Grunfeld C, Feingold K. Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Atherosclerosis. 2004 Sep; 176(1):37-44. PMID: 15306172.
      View in: PubMed
    121. Presland RB, Coulombe PA, Eckert RL, Mao-Qiang M, Feingold K, Elias PM. Barrier function in transgenic mice overexpressing K16, involucrin, and filaggrin in the suprabasal epidermis. J Invest Dermatol. 2004 Sep; 123(3):603-6. PMID: 15304104.
      View in: PubMed
    122. Mao-Qiang M, Fowler AJ, Schmuth M, Lau P, Chang S, Brown BE, Moser AH, Michalik L, Desvergne B, Wahli W, Li M, Metzger D, Chambon PH, Elias PM, Feingold K. Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. J Invest Dermatol. 2004 Aug; 123(2):305-12. PMID: 15245430.
      View in: PubMed
    123. Schmuth M, Elias PM, Hanley K, Lau P, Moser A, Willson TM, Bikle DD, Feingold K. The effect of LXR activators on AP-1 proteins in keratinocytes. J Invest Dermatol. 2004 Jul; 123(1):41-8. PMID: 15191540.
      View in: PubMed
    124. Fluhr JW, Mao-Qiang M, Brown BE, Hachem JP, Moskowitz DG, Demerjian M, Haftek M, Serre G, Crumrine D, Mauro TM, Elias PM, Feingold K. Functional consequences of a neutral pH in neonatal rat stratum corneum. J Invest Dermatol. 2004 Jul; 123(1):140-51. PMID: 15191554.
      View in: PubMed
    125. Kim MS, Shigenaga J, Moser A, Grunfeld C, Feingold K. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. Am J Physiol Endocrinol Metab. 2004 Oct; 287(4):E731-8. PMID: 15198932.
      View in: PubMed
    126. Bikle DD, Chang S, Crumrine D, Elalieh H, Man MQ, Dardenne O, Xie Z, Arnaud RS, Feingold K, Elias PM. Mice lacking 25OHD 1alpha-hydroxylase demonstrate decreased epidermal differentiation and barrier function. J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):347-53. PMID: 15225799.
      View in: PubMed
    127. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold K, Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004 Jul; 45(7):1169-96. PMID: 15102878.
      View in: PubMed
    128. Bikle DD, Chang S, Crumrine D, Elalieh H, Man MQ, Choi EH, Dardenne O, Xie Z, Arnaud RS, Feingold K, Elias PM. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol. 2004 Apr; 122(4):984-92. PMID: 15102089.
      View in: PubMed
    129. Schmuth M, Fluhr JW, Crumrine DC, Uchida Y, Hachem JP, Behne M, Moskowitz DG, Christiano AM, Feingold K, Elias PM. Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis). J Invest Dermatol. 2004 Apr; 122(4):909-22. PMID: 15102081.
      View in: PubMed
    130. Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, Chang S, Lau P, Fowler AJ, Chuang G, Moser AH, Brown BE, Mao-Qiang M, Uchida Y, Schoonjans K, Auwerx J, Chambon P, Willson TM, Elias PM, Feingold K. Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol. 2004 Apr; 122(4):971-83. PMID: 15102088.
      View in: PubMed
    131. Fluhr JW, Behne MJ, Brown BE, Moskowitz DG, Selden C, Mao-Qiang M, Mauro TM, Elias PM, Feingold K. Stratum corneum acidification in neonatal skin: secretory phospholipase A2 and the sodium/hydrogen antiporter-1 acidify neonatal rat stratum corneum. J Invest Dermatol. 2004 Feb; 122(2):320-9. PMID: 15009712.
      View in: PubMed
    132. Elias PM, Crumrine D, Rassner U, Hachem JP, Menon GK, Man W, Choy MH, Leypoldt L, Feingold K, Williams ML. Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol. 2004 Feb; 122(2):314-9. PMID: 15009711.
      View in: PubMed
    133. Feingold K, Kim MS, Shigenaga J, Moser A, Grunfeld C. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am J Physiol Endocrinol Metab. 2004 Feb; 286(2):E201-7. PMID: 14701665.
      View in: PubMed
    134. Stone SJ, Myers HM, Watkins SM, Brown BE, Feingold K, Elias PM, Farese RV. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem. 2004 Mar 19; 279(12):11767-76. PMID: 14668353.
      View in: PubMed
    135. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold K, Elias PM. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol. 2003 Aug; 121(2):345-53. PMID: 12880427.
      View in: PubMed
    136. Behne MJ, Barry NP, Hanson KM, Aronchik I, Clegg RW, Gratton E, Feingold K, Holleran WM, Elias PM, Mauro TM. Neonatal development of the stratum corneum pH gradient: localization and mechanisms leading to emergence of optimal barrier function. J Invest Dermatol. 2003 Jun; 120(6):998-1006. PMID: 12787127.
      View in: PubMed
    137. Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res. 2003 Sep; 44(9):1728-36. PMID: 12777468.
      View in: PubMed
    138. Fluhr JW, Mao-Qiang M, Brown BE, Wertz PW, Crumrine D, Sundberg JP, Feingold K, Elias PM. Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J Invest Dermatol. 2003 May; 120(5):728-37. PMID: 12713573.
      View in: PubMed
    139. Schmuth M, Elias PM, Feingold K. [Beyond glucocorticoids, retinoids and vitamin D--the evolution of nuclear hormone type transcription factor targeting in the skin]. J Dtsch Dermatol Ges. 2003 May; 1(5):352-62. PMID: 16285300.
      View in: PubMed
    140. Kao JS, Fluhr JW, Man MQ, Fowler AJ, Hachem JP, Crumrine D, Ahn SK, Brown BE, Elias PM, Feingold K. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol. 2003 Mar; 120(3):456-64. PMID: 12603860.
      View in: PubMed
    141. Fowler AJ, Sheu MY, Schmuth M, Kao J, Fluhr JW, Rhein L, Collins JL, Willson TM, Mangelsdorf DJ, Elias PM, Feingold K. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol. 2003 Feb; 120(2):246-55. PMID: 12542530.
      View in: PubMed
    142. Staprans I, Pan XM, Rapp JH, Feingold K. Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum. J Lipid Res. 2003 Apr; 44(4):705-15. PMID: 12562864.
      View in: PubMed
    143. Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C. Repression of farnesoid X receptor during the acute phase response. J Biol Chem. 2003 Mar 14; 278(11):8988-95. PMID: 12519762.
      View in: PubMed
    144. Elias PM, Tsai J, Menon GK, Holleran WM, Feingold K. The potential of metabolic interventions to enhance transdermal drug delivery. J Investig Dermatol Symp Proc. 2002 Dec; 7(1):79-85. PMID: 12518797.
      View in: PubMed
    145. Schmuth M, Schoonjans K, Yu QC, Fluhr JW, Crumrine D, Hachem JP, Lau P, Auwerx J, Elias PM, Feingold K. Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero. J Invest Dermatol. 2002 Dec; 119(6):1298-303. PMID: 12485431.
      View in: PubMed
    146. Elias P, Ahn S, Brown B, Crumrine D, Feingold K. Origin of the epidermal calcium gradient: regulation by barrier status and role of active vs passive mechanisms. J Invest Dermatol. 2002 Dec; 119(6):1269-74. PMID: 12485427.
      View in: PubMed
    147. Bikle DD, Ng D, Oda Y, Hanley K, Feingold K, Xie Z. The vitamin D response element of the involucrin gene mediates its regulation by 1,25-dihydroxyvitamin D3. J Invest Dermatol. 2002 Nov; 119(5):1109-13. PMID: 12445200.
      View in: PubMed
    148. Elias PM, Ahn SK, Denda M, Brown BE, Crumrine D, Kimutai LK, Kömüves L, Lee SH, Feingold K. Modulations in epidermal calcium regulate the expression of differentiation-specific markers. J Invest Dermatol. 2002 Nov; 119(5):1128-36. PMID: 12445203.
      View in: PubMed
    149. Sato J, Denda M, Chang S, Elias PM, Feingold K. Abrupt decreases in environmental humidity induce abnormalities in permeability barrier homeostasis. J Invest Dermatol. 2002 Oct; 119(4):900-4. PMID: 12406336.
      View in: PubMed
    150. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver. Am J Physiol Endocrinol Metab. 2003 Jan; 284(1):E228-36. PMID: 12388159.
      View in: PubMed
    151. Nonogaki K, Memon RA, Grunfeld C, Feingold K, Tecott LH. Altered gene expressions involved in energy expenditure in 5-HT(2C) receptor mutant mice. Biochem Biophys Res Commun. 2002 Jul 12; 295(2):249-54. PMID: 12150939.
      View in: PubMed
    152. Ye J, Garg A, Calhoun C, Feingold K, Elias PM, Ghadially R. Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family. Exp Dermatol. 2002 Jun; 11(3):209-16. PMID: 12102659.
      View in: PubMed
    153. Elias PM, Schmuth M, Uchida Y, Rice RH, Behne M, Crumrine D, Feingold K, Holleran WM, Pharm D. Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp Dermatol. 2002 Jun; 11(3):248-56. PMID: 12102664.
      View in: PubMed
    154. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem Biophys Res Commun. 2002 Apr 26; 293(1):145-9. PMID: 12054576.
      View in: PubMed
    155. Chuong CM, Nickoloff BJ, Elias PM, Goldsmith LA, Macher E, Maderson PA, Sundberg JP, Tagami H, Plonka PM, Thestrup-Pederson K, Bernard BA, Schröder JM, Dotto P, Chang CM, Williams ML, Feingold K, King LE, Kligman AM, Rees JL, Christophers E. What is the 'true' function of skin? Exp Dermatol. 2002 Apr; 11(2):159-87. PMID: 11994143.
      View in: PubMed
    156. Kömüves LG, Schmuth M, Fowler AJ, Elias PM, Hanley K, Man MQ, Moser AH, Lobaccaro JM, Williams ML, Mangelsdorf DJ, Feingold K. Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. J Invest Dermatol. 2002 Jan; 118(1):25-34. PMID: 11851872.
      View in: PubMed
    157. Sheu MY, Fowler AJ, Kao J, Schmuth M, Schoonjans K, Auwerx J, Fluhr JW, Man MQ, Elias PM, Feingold K. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol. 2002 Jan; 118(1):94-101. PMID: 11851881.
      View in: PubMed
    158. Faggioni R, Feingold K, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 2001 Dec; 15(14):2565-71. PMID: 11726531.
      View in: PubMed
    159. Tsuruoka H, Khovidhunkit W, Brown BE, Fluhr JW, Elias PM, Feingold K. Scavenger receptor class B type I is expressed in cultured keratinocytes and epidermis. Regulation in response to changes in cholesterol homeostasis and barrier requirements. J Biol Chem. 2002 Jan 25; 277(4):2916-22. PMID: 11707442.
      View in: PubMed
    160. Schmuth M, Yosipovitch G, Williams ML, Weber F, Hintner H, Ortiz-Urda S, Rappersberger K, Crumrine D, Feingold K, Elias PM. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol. 2001 Oct; 117(4):837-47. PMID: 11676820.
      View in: PubMed
    161. Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines. J Lipid Res. 2001 Oct; 42(10):1636-44. PMID: 11590220.
      View in: PubMed
    162. Whang SW, Lee SH, Elias PM, Feingold K, Choi EH, Ahn SK. Intralesional steroids reduce inflammation from extravasated chemotherapeutic agents. Br J Dermatol. 2001 Oct; 145(4):680-2. PMID: 11703309.
      View in: PubMed
    163. Elias PM, Feingold K. Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol. 2001 Aug; 137(8):1079-81. PMID: 11493102.
      View in: PubMed
    164. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold K, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol. 2001 Jul; 117(1):44-51. PMID: 11442748.
      View in: PubMed
    165. Memon RA, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1. J Biol Chem. 2001 Aug 10; 276(32):30118-26. PMID: 11406622.
      View in: PubMed
    166. Khovidhunkit W, Shigenaga JK, Moser AH, Feingold K, Grunfeld C. Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase. J Lipid Res. 2001 Jun; 42(6):967-75. PMID: 11369805.
      View in: PubMed
    167. Memon RA, Holleran WM, Uchida Y, Moser AH, Grunfeld C, Feingold K. Regulation of sphingolipid and glycosphingolipid metabolism in extrahepatic tissues by endotoxin. J Lipid Res. 2001 Mar; 42(3):452-9. PMID: 11254758.
      View in: PubMed
    168. Kao JS, Garg A, Mao-Qiang M, Crumrine D, Ghadially R, Feingold K, Elias PM. Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol. 2001 Mar; 116(3):443-51. PMID: 11231319.
      View in: PubMed
    169. Hanley K, Wood L, Ng DC, He SS, Lau P, Moser A, Elias PM, Bikle DD, Williams ML, Feingold K. Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D. J Lipid Res. 2001 Mar; 42(3):390-8. PMID: 11254751.
      View in: PubMed
    170. Memon RA, Grunfeld C, Feingold K. TNF-alpha is not the cause of fatty liver disease in obese diabetic mice. Nat Med. 2001 Jan; 7(1):2-3. PMID: 11135585.
      View in: PubMed
    171. Elias PM, Feingold K. Coordinate regulation of epidermal differentiation and barrier homeostasis. Skin Pharmacol Appl Skin Physiol. 2001; 14 Suppl 1:28-34. PMID: 11509904.
      View in: PubMed
    172. Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold K, Elias PM. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol. 2001 Jan; 137(1):53-9. PMID: 11176661.
      View in: PubMed
    173. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold K. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology. 2000 Nov; 141(11):4021-31. PMID: 11089532.
      View in: PubMed
    174. Kömüves LG, Hanley K, Man MQ, Elias PM, Williams ML, Feingold K. Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis. J Invest Dermatol. 2000 Sep; 115(3):361-7. PMID: 10951269.
      View in: PubMed
    175. Kömüves LG, Hanley K, Lefebvre AM, Man MQ, Ng DC, Bikle DD, Williams ML, Elias PM, Auwerx J, Feingold K. Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol. 2000 Sep; 115(3):353-60. PMID: 10951268.
      View in: PubMed
    176. Schmuth M, Man MQ, Weber F, Gao W, Feingold K, Fritsch P, Elias PM, Holleran WM. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol. 2000 Sep; 115(3):459-66. PMID: 10951284.
      View in: PubMed
    177. Memon RA, Staprans I, Noor M, Holleran WM, Uchida Y, Moser AH, Feingold K, Grunfeld C. Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol. 2000 Jun; 20(6):1536-42. PMID: 10845869.
      View in: PubMed
    178. Khovidhunkit W, Memon RA, Feingold K, Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis. 2000 Jun; 181 Suppl 3:S462-72. PMID: 10839741.
      View in: PubMed
    179. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem. 2000 May 26; 275(21):16390-9. PMID: 10747970.
      View in: PubMed
    180. Faggioni R, Moser A, Feingold K, Grunfeld C. Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol. 2000 May; 156(5):1781-7. PMID: 10793089; PMCID: PMC1876910.
    181. Hanley K, Kömüves LG, Ng DC, Schoonjans K, He SS, Lau P, Bikle DD, Williams ML, Elias PM, Auwerx J, Feingold K. Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha. J Biol Chem. 2000 Apr 14; 275(15):11484-91. PMID: 10753967.
      View in: PubMed
    182. Hanley K, Ng DC, He SS, Lau P, Min K, Elias PM, Bikle DD, Mangelsdorf DJ, Williams ML, Feingold K. Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription. J Invest Dermatol. 2000 Mar; 114(3):545-53. PMID: 10692116.
      View in: PubMed
    183. Staprans I, Pan XM, Rapp JH, Grunfeld C, Feingold K. Oxidized cholesterol in the diet accelerates the development of atherosclerosis in LDL receptor- and apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2000 Mar; 20(3):708-14. PMID: 10712395.
      View in: PubMed
    184. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold K, Grunfeld C, Fantuzzi G. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A. 2000 Feb 29; 97(5):2367-72. PMID: 10681432; PMCID: PMC15807.
    185. Memon RA, Hotamisligil GS, Wiesbrock SM, Uysal KT, Faggioni R, Moser AH, Feingold K, Grunfeld C. Upregulation of uncoupling protein 2 mRNA in genetic obesity: lack of an essential role for leptin, hyperphagia, increased tissue lipid content, and TNF-alpha. Biochim Biophys Acta. 2000 Feb 24; 1484(1):41-50. PMID: 10685029.
      View in: PubMed
    186. Denda M, Tsuchiya T, Elias PM, Feingold K. Stress alters cutaneous permeability barrier homeostasis. Am J Physiol Regul Integr Comp Physiol. 2000 Feb; 278(2):R367-72. PMID: 10666137.
      View in: PubMed
    187. Elias P, Man MQ, Williams ML, Feingold K, Magin T. Barrier function in K-10 heterozygote knockout mice. J Invest Dermatol. 2000 Feb; 114(2):396-7. PMID: 10722328.
      View in: PubMed
    188. Khovidhunkit W, Memon RA, Shigenaga JK, Pang M, Schambelan M, Mulligan K, Feingold K, Grunfeld C. Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism. 1999 Dec; 48(12):1524-31. PMID: 10599983.
      View in: PubMed
    189. Hanley K, Kömüves LG, Bass NM, He SS, Jiang Y, Crumrine D, Appel R, Friedman M, Bettencourt J, Min K, Elias PM, Williams ML, Feingold K. Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators. J Invest Dermatol. 1999 Nov; 113(5):788-95. PMID: 10571735.
      View in: PubMed
    190. Rassner U, Feingold K, Crumrine DA, Elias PM. Coordinate assembly of lipids and enzyme proteins into epidermal lamellar bodies. Tissue Cell. 1999 Oct; 31(5):489-98. PMID: 10612259.
      View in: PubMed
    191. Elias PM, Wood LC, Feingold K. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat. 1999 Sep; 10(3):119-26. PMID: 10444104.
      View in: PubMed
    192. Memon RA, Bass NM, Moser AH, Fuller J, Appel R, Grunfeld C, Feingold K. Down-regulation of liver and heart specific fatty acid binding proteins by endotoxin and cytokines in vivo. Biochim Biophys Acta. 1999 Aug 25; 1440(1):118-26. PMID: 10477831.
      View in: PubMed
    193. Man MQ, Wood L, Elias PM, Feingold K. Cutaneous barrier repair and pathophysiology following barrier disruption in IL-1 and TNF type I receptor deficient mice. Exp Dermatol. 1999 Aug; 8(4):261-6. PMID: 10439223.
      View in: PubMed
    194. Memon RA, Holleran WM, Uchida Y, Moser AH, Ichikawa S, Hirabayashi Y, Grunfeld C, Feingold K. Regulation of glycosphingolipid metabolism in liver during the acute phase response. J Biol Chem. 1999 Jul 9; 274(28):19707-13. PMID: 10391911.
      View in: PubMed
    195. Memon RA, Fuller J, Moser AH, Feingold K, Grunfeld C. In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. Am J Physiol. 1999 Jul; 277(1 Pt 2):R94-103. PMID: 10409262.
      View in: PubMed
    196. Wood LC, Ashby MN, Grunfeld C, Feingold K. Cloning of murine translation initiation factor 6 and functional analysis of the homologous sequence YPR016c in Saccharomyces cerevisiae. J Biol Chem. 1999 Apr 23; 274(17):11653-9. PMID: 10206977.
      View in: PubMed
    197. Kömüves LG, Hanley K, Jiang Y, Katagiri C, Elias PM, Williams ML, Feingold K. Induction of selected lipid metabolic enzymes and differentiation-linked structural proteins by air exposure in fetal rat skin explants. J Invest Dermatol. 1999 Mar; 112(3):303-9. PMID: 10084306.
      View in: PubMed
    198. Grunfeld C, Marshall M, Shigenaga JK, Moser AH, Tobias P, Feingold K. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J Lipid Res. 1999 Feb; 40(2):245-52. PMID: 9925653.
      View in: PubMed
    199. Staprans I, Hardman DA, Pan XM, Feingold K. Effect of oxidized lipids in the diet on oxidized lipid levels in postprandial serum chylomicrons of diabetic patients. Diabetes Care. 1999 Feb; 22(2):300-6. PMID: 10333949.
      View in: PubMed
    200. Feingold K, Memon RA, Moser AH, Shigenaga JK, Grunfeld C. Endotoxin and interleukin-1 decrease hepatic lipase mRNA levels. Atherosclerosis. 1999 Feb; 142(2):379-87. PMID: 10030389.
      View in: PubMed
    201. Memon RA, Fuller J, Moser AH, Smith PJ, Grunfeld C, Feingold K. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes. 1999 Jan; 48(1):121-7. PMID: 9892232.
      View in: PubMed
    202. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold K, Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol. 1999 Jan; 276(1 Pt 2):R136-42. PMID: 9887187.
      View in: PubMed
    203. Mauro T, Bench G, Sidderas-Haddad E, Feingold K, Elias P, Cullander C. Acute barrier perturbation abolishes the Ca2+ and K+ gradients in murine epidermis: quantitative measurement using PIXE. J Invest Dermatol. 1998 Dec; 111(6):1198-201. PMID: 9856840.
      View in: PubMed
    204. Denda M, Sato J, Tsuchiya T, Elias PM, Feingold K. Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol. 1998 Nov; 111(5):873-8. PMID: 9804352.
      View in: PubMed
    205. Zettersten E, Man MQ, Sato J, Denda M, Farrell A, Ghadially R, Williams ML, Feingold K, Elias PM. Recessive x-linked ichthyosis: role of cholesterol-sulfate accumulation in the barrier abnormality. J Invest Dermatol. 1998 Nov; 111(5):784-90. PMID: 9804339.
      View in: PubMed
    206. Harris IR, Farrell AM, Memon RA, Grunfeld C, Elias PM, Feingold K. Expression and regulation of mRNA for putative fatty acid transport related proteins and fatty acyl CoA synthase in murine epidermis and cultured human keratinocytes. J Invest Dermatol. 1998 Nov; 111(5):722-6. PMID: 9804328.
      View in: PubMed
    207. Denda M, Sato J, Masuda Y, Tsuchiya T, Koyama J, Kuramoto M, Elias PM, Feingold K. Exposure to a dry environment enhances epidermal permeability barrier function. J Invest Dermatol. 1998 Nov; 111(5):858-63. PMID: 9804350.
      View in: PubMed
    208. Iribarren C, Jacobs DR, Sidney S, Claxton AJ, Feingold K. Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases. Epidemiol Infect. 1998 Oct; 121(2):335-47. PMID: 9825784; PMCID: PMC2809530.
    209. Hanley K, Feingold K, Kömüves LG, Elias PM, Muglia LJ, Majzoub JA, Williams ML. Glucocorticoid deficiency delays stratum corneum maturation in the fetal mouse. J Invest Dermatol. 1998 Sep; 111(3):440-4. PMID: 9740238.
      View in: PubMed
    210. Williams ML, Feingold K. Barrier function of neonatal skin. J Pediatr. 1998 Sep; 133(3):467-8. PMID: 9738737.
      View in: PubMed
    211. Kömüves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold K. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol. 1998 Sep; 111(3):429-33. PMID: 9740236.
      View in: PubMed
    212. Feingold K, Memon RA, Moser AH, Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis. 1998 Aug; 139(2):307-15. PMID: 9712337.
      View in: PubMed
    213. Williams ML, Hanley K, Elias PM, Feingold K. Ontogeny of the epidermal permeability barrier. J Investig Dermatol Symp Proc. 1998 Aug; 3(2):75-9. PMID: 9734818.
      View in: PubMed
    214. Memon RA, Holleran WM, Moser AH, Seki T, Uchida Y, Fuller J, Shigenaga JK, Grunfeld C, Feingold K. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol. 1998 Aug; 18(8):1257-65. PMID: 9714132.
      View in: PubMed
    215. Lee SH, Choi EH, Feingold K, Jiang S, Ahn SK. Iontophoresis itself on hairless mouse skin induces the loss of the epidermal calcium gradient without skin barrier impairment. J Invest Dermatol. 1998 Jul; 111(1):39-43. PMID: 9665384.
      View in: PubMed
    216. Memon RA, Fuller J, Moser AH, Smith PJ, Feingold K, Grunfeld C. In vivo regulation of acyl-CoA synthetase mRNA and activity by endotoxin and cytokines. Am J Physiol. 1998 Jul; 275(1 Pt 1):E64-72. PMID: 9688875.
      View in: PubMed
    217. Navasa M, Gordon DA, Hariharan N, Jamil H, Shigenaga JK, Moser A, Fiers W, Pollock A, Grunfeld C, Feingold K. Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines. J Lipid Res. 1998 Jun; 39(6):1220-30. PMID: 9643353.
      View in: PubMed
    218. Staprans I, Pan XM, Rapp JH, Feingold K. Oxidized cholesterol in the diet accelerates the development of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 1998 Jun; 18(6):977-83. PMID: 9633940.
      View in: PubMed
    219. Mauro T, Holleran WM, Grayson S, Gao WN, Man MQ, Kriehuber E, Behne M, Feingold K, Elias PM. Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res. 1998 Apr; 290(4):215-22. PMID: 9617442.
      View in: PubMed
    220. Elias PM, Nau P, Hanley K, Cullander C, Crumrine D, Bench G, Sideras-Haddad E, Mauro T, Williams ML, Feingold K. Formation of the epidermal calcium gradient coincides with key milestones of barrier ontogenesis in the rodent. J Invest Dermatol. 1998 Apr; 110(4):399-404. PMID: 9540982.
      View in: PubMed
    221. Hanley K, Jiang Y, He SS, Friedman M, Elias PM, Bikle DD, Williams ML, Feingold K. Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha. J Invest Dermatol. 1998 Apr; 110(4):368-75. PMID: 9540977.
      View in: PubMed
    222. Faggioni R, Shigenaga J, Moser A, Feingold K, Grunfeld C. Induction of UCP2 gene expression by LPS: a potential mechanism for increased thermogenesis during infection. Biochem Biophys Res Commun. 1998 Mar 6; 244(1):75-8. PMID: 9514886.
      View in: PubMed
    223. Harris IR, Farrell AM, Holleran WM, Jackson S, Grunfeld C, Elias PM, Feingold K. Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis. J Lipid Res. 1998 Feb; 39(2):412-22. PMID: 9508001.
      View in: PubMed
    224. Chujor CS, Feingold K, Elias PM, Holleran WM. Glucosylceramide synthase activity in murine epidermis: quantitation, localization, regulation, and requirement for barrier homeostasis. J Lipid Res. 1998 Feb; 39(2):277-85. PMID: 9507988.
      View in: PubMed
    225. Memon RA, Feingold K, Moser AH, Fuller J, Grunfeld C. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol. 1998 Feb; 274(2 Pt 1):E210-7. PMID: 9486149.
      View in: PubMed
    226. Claxton AJ, Jacobs DR, Iribarren C, Welles SL, Sidney S, Feingold K. Association between serum total cholesterol and HIV infection in a high-risk cohort of young men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jan 1; 17(1):51-7. PMID: 9436759.
      View in: PubMed
    227. Faggioni R, Fantuzzi G, Fuller J, Dinarello CA, Feingold K, Grunfeld C. IL-1 beta mediates leptin induction during inflammation. Am J Physiol. 1998 Jan; 274(1 Pt 2):R204-8. PMID: 9458919.
      View in: PubMed
    228. Feingold K, Hardardóttir I, Grunfeld C. Beneficial effects of cytokine induced hyperlipidemia. Z Ernahrungswiss. 1998; 37 Suppl 1:66-74. PMID: 9558731.
      View in: PubMed
    229. Feingold K, Grunfeld C. Lipoproteins: are they important components of host defense? Hepatology. 1997 Dec; 26(6):1685-6. PMID: 9398019.
      View in: PubMed
    230. Harris IR, Farrell AM, Grunfeld C, Holleran WM, Elias PM, Feingold K. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J Invest Dermatol. 1997 Dec; 109(6):783-7. PMID: 9406821.
      View in: PubMed
    231. Grunfeld C, Doerrler W, Pang M, Jensen P, Weisgraber KH, Feingold K. Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1997 Nov; 82(11):3734-40. PMID: 9360533.
      View in: PubMed
    232. Hanley K, Devaskar UP, Hicks SJ, Jiang Y, Crumrine D, Elias PM, Williams ML, Feingold K. Hypothyroidism delays fetal stratum corneum development in mice. Pediatr Res. 1997 Nov; 42(5):610-4. PMID: 9357932.
      View in: PubMed
    233. Zettersten EM, Ghadially R, Feingold K, Crumrine D, Elias PM. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J Am Acad Dermatol. 1997 Sep; 37(3 Pt 1):403-8. PMID: 9308554.
      View in: PubMed
    234. Hanley K, Jiang Y, Crumrine D, Bass NM, Appel R, Elias PM, Williams ML, Feingold K. Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest. 1997 Aug 1; 100(3):705-12. PMID: 9239419; PMCID: PMC508240.
    235. Memon RA, Shechter I, Moser AH, Shigenaga JK, Grunfeld C, Feingold K. Endotoxin, tumor necrosis factor, and interleukin-1 decrease hepatic squalene synthase activity, protein, and mRNA levels in Syrian hamsters. J Lipid Res. 1997 Aug; 38(8):1620-9. PMID: 9300784.
      View in: PubMed
    236. Faggioni R, Fuller J, Moser A, Feingold K, Grunfeld C. LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. Am J Physiol. 1997 Jul; 273(1 Pt 2):R181-6. PMID: 9249548.
      View in: PubMed
    237. Funk JL, Moser AH, Grunfeld C, Feingold K. Parathyroid hormone-related protein is induced in the adult liver during endotoxemia and stimulates the hepatic acute phase response. Endocrinology. 1997 Jul; 138(7):2665-73. PMID: 9202202.
      View in: PubMed
    238. Denda M, Kitamura K, Elias PM, Feingold K. trans-4-(Aminomethyl)cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. J Invest Dermatol. 1997 Jul; 109(1):84-90. PMID: 9204960.
      View in: PubMed
    239. Hanley K, Jiang Y, Katagiri C, Feingold K, Williams ML. Epidermal steroid sulfatase and cholesterol sulfotransferase are regulated during late gestation in the fetal rat. J Invest Dermatol. 1997 Jun; 108(6):871-5. PMID: 9182813.
      View in: PubMed
    240. Wood LC, Stalder AK, Liou A, Campbell IL, Grunfeld C, Elias PM, Feingold K. Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin. Exp Dermatol. 1997 Apr; 6(2):98-104. PMID: 9209892.
      View in: PubMed
    241. Hanley K, Jiang Y, Holleran WM, Elias PM, Williams ML, Feingold K. Glucosylceramide metabolism is regulated during normal and hormonally stimulated epidermal barrier development in the rat. J Lipid Res. 1997 Mar; 38(3):576-84. PMID: 9101438.
      View in: PubMed
    242. Hardardóttir I, Sipe J, Moser AH, Fielding CJ, Feingold K, Grünfeld C. LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters. Biochim Biophys Acta. 1997 Feb 18; 1344(3):210-20. PMID: 9059511.
      View in: PubMed
    243. Hanley K, Jiang Y, Elias PM, Feingold K, Williams ML. Acceleration of barrier ontogenesis in vitro through air exposure. Pediatr Res. 1997 Feb; 41(2):293-9. PMID: 9029653.
      View in: PubMed
    244. Mao-Qiang M, Mauro T, Bench G, Warren R, Elias PM, Feingold K. Calcium and potassium inhibit barrier recovery after disruption, independent of the type of insult in hairless mice. Exp Dermatol. 1997 Feb; 6(1):36-40. PMID: 9067705.
      View in: PubMed
    245. Denda M, Brown BE, Elias PM, Feingold K. Epidermal injury stimulates prenylation in the epidermis of hairless mice. Arch Dermatol Res. 1997 Jan; 289(2):104-10. PMID: 9049045.
      View in: PubMed
    246. Yoshida M, Roth RI, Grunfeld C, Feingold K, Levin J. Pharmacokinetics, biological effects, and distribution of (1-->3)-beta-D-glucan in blood and organs in rabbits. Mediators Inflamm. 1997; 6(4):279-83. PMID: 18472859; PMCID: PMC2365862.
    247. Liou A, Elias PM, Grunfeld C, Feingold K, Wood LC. Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis. J Invest Dermatol. 1997 Jan; 108(1):73-7. PMID: 8980291.
      View in: PubMed
    248. Grunfeld C, Pang M, Shigenaga JK, Jensen P, Lallone R, Friedman J, Feingold K. Serum leptin levels in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1996 Dec; 81(12):4342-6. PMID: 8954039.
      View in: PubMed
    249. Elias PM, Ansel JC, Woods LD, Feingold K. Signaling networks in barrier homeostasis. The mystery widens. Arch Dermatol. 1996 Dec; 132(12):1505-6. PMID: 8961883.
      View in: PubMed
    250. Nonogaki K, Pan XM, Moser AH, Shigenaga J, Staprans I, Sakamoto N, Grunfeld C, Feingold K. LIF and CNTF, which share the gp130 transduction system, stimulate hepatic lipid metabolism in rats. Am J Physiol. 1996 Sep; 271(3 Pt 1):E521-8. PMID: 8843746.
      View in: PubMed
    251. Yoshida M, Roth RI, Grunfeld C, Feingold K, Levin J. Soluble (1-->3)-beta-D-glucan purified from Candida albicans: biologic effects and distribution in blood and organs in rabbits. J Lab Clin Med. 1996 Jul; 128(1):103-14. PMID: 8759942.
      View in: PubMed
    252. Hardardóttir I, Moser AH, Fuller J, Fielding C, Feingold K, Grünfeld C. Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters. J Clin Invest. 1996 Jun 1; 97(11):2585-92. PMID: 8647952; PMCID: PMC507345.
    253. Marcelino JJ, Feingold K. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers. Am J Med. 1996 Jun; 100(6):605-10. PMID: 8678079.
      View in: PubMed
    254. Hanley K, Rassner U, Jiang Y, Vansomphone D, Crumrine D, Komüves L, Elias PM, Feingold K, Williams ML. Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay by testosterone. J Clin Invest. 1996 Jun 1; 97(11):2576-84. PMID: 8647951; PMCID: PMC507344.
    255. Tsai JC, Guy RH, Thornfeldt CR, Gao WN, Feingold K, Elias PM. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. J Pharm Sci. 1996 Jun; 85(6):643-8. PMID: 8773963.
      View in: PubMed
    256. Man MQ M, Feingold K, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol. 1996 May; 106(5):1096-101. PMID: 8618046.
      View in: PubMed
    257. Ghadially R, Brown BE, Hanley K, Reed JT, Feingold K, Elias PM. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. J Invest Dermatol. 1996 May; 106(5):1064-9. PMID: 8618040.
      View in: PubMed
    258. Denda M, Wood LC, Emami S, Calhoun C, Brown BE, Elias PM, Feingold K. The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res. 1996 May; 288(5-6):230-8. PMID: 8738565.
      View in: PubMed
    259. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold K. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest. 1996 May 1; 97(9):2152-7. PMID: 8621806; PMCID: PMC507291.
    260. Staprãns I, Rapp JH, Pan XM, Hardman DA, Feingold K. Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 1996 Apr; 16(4):533-8. PMID: 8624775.
      View in: PubMed
    261. Funk JL, Moser AH, Strewler GJ, Feingold K, Grünfeld C. Parathyroid hormone-related protein is induced during lethal endotoxemia and contributes to endotoxin-induced mortality in rodents. Mol Med. 1996 Mar; 2(2):204-10. PMID: 8726463; PMCID: PMC2230122.
    262. Hanley K, Rassner U, Elias PM, Williams ML, Feingold K. Epidermal barrier ontogenesis: maturation in serum-free media and acceleration by glucocorticoids and thyroid hormone but not selected growth factors. J Invest Dermatol. 1996 Mar; 106(3):404-11. PMID: 8648168.
      View in: PubMed
    263. Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold K. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol. 1996 Mar; 106(3):397-403. PMID: 8648167.
      View in: PubMed
    264. Nonogaki K, Moser AH, Shigenaga J, Feingold K, Grunfeld C. Beta-nerve growth factor as a mediator of the acute phase response in vivo. Biochem Biophys Res Commun. 1996 Feb 27; 219(3):956-61. PMID: 8645286.
      View in: PubMed
    265. Feingold K, Spady DK, Pollock AS, Moser AH, Grunfeld C. Endotoxin, TNF, and IL-1 decrease cholesterol 7 alpha-hydroxylase mRNA levels and activity. J Lipid Res. 1996 Feb; 37(2):223-8. PMID: 9026521.
      View in: PubMed
    266. Staprans I, Rapp JH, Pan XM, Feingold K. Oxidized lipids in the diet are incorporated by the liver into very low density lipoprotein in rats. J Lipid Res. 1996 Feb; 37(2):420-30. PMID: 9026539.
      View in: PubMed
    267. Mao-Qiang M, Jain M, Feingold K, Elias PM. Secretory phospholipase A2 activity is required for permeability barrier homeostasis. J Invest Dermatol. 1996 Jan; 106(1):57-63. PMID: 8592082.
      View in: PubMed
    268. Taljebini M, Warren R, Mao-Oiang M, Lane E, Elias PM, Feingold K. Cutaneous permeability barrier repair following various types of insults: kinetics and effects of occlusion. Skin Pharmacol. 1996; 9(2):111-9. PMID: 8722605.
      View in: PubMed
    269. Grunfeld C, Feingold K. Regulation of lipid metabolism by cytokines during host defense. Nutrition. 1996 Jan; 12(1 Suppl):S24-6. PMID: 8850215.
      View in: PubMed
    270. Hardardóttir I, Grunfeld C, Feingold K. Effects of endotoxin on lipid metabolism. Biochem Soc Trans. 1995 Nov; 23(4):1013-8. PMID: 8654672.
      View in: PubMed
    271. Yang L, Mao-Qiang M, Taljebini M, Elias PM, Feingold K. Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment. Br J Dermatol. 1995 Nov; 133(5):679-85. PMID: 8555016.
      View in: PubMed
    272. Nonogaki K, Pan XM, Moser AH, Staprans I, Feingold K, Grunfeld C. Keratinocyte growth factor increases fatty acid mobilization and hepatic triglyceride secretion in rats. Endocrinology. 1995 Oct; 136(10):4278-84. PMID: 7664645.
      View in: PubMed
    273. Nonogaki K, Moser AH, Pan XM, Staprans I, Grunfeld C, Feingold K. Lipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo. J Lipid Res. 1995 Sep; 36(9):1987-95. PMID: 8558086.
      View in: PubMed
    274. Mao-Qiang M, Feingold K, Jain M, Elias PM. Extracellular processing of phospholipids is required for permeability barrier homeostasis. J Lipid Res. 1995 Sep; 36(9):1925-35. PMID: 8558081.
      View in: PubMed
    275. Funk JL, Lausier J, Moser AH, Shigenaga JK, Huling S, Nissenson RA, Strewler GJ, Grunfeld C, Feingold K. Endotoxin induces parathyroid hormone-related protein gene expression in splenic stromal and smooth muscle cells, not in splenic lymphocytes. Endocrinology. 1995 Aug; 136(8):3412-21. PMID: 7628377.
      View in: PubMed
    276. Mao-Qiang M, Brown BE, Wu-Pong S, Feingold K, Elias PM. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol. 1995 Jul; 131(7):809-16. PMID: 7611797.
      View in: PubMed
    277. Feingold K, Pollock AS, Moser AH, Shigenaga JK, Grunfeld C. Discordant regulation of proteins of cholesterol metabolism during the acute phase response. J Lipid Res. 1995 Jul; 36(7):1474-82. PMID: 7595071.
      View in: PubMed
    278. Read TE, Grunfeld C, Kumwenda ZL, Calhoun MC, Kane JP, Feingold K, Rapp JH. Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med. 1995 Jul 1; 182(1):267-72. PMID: 7790821; PMCID: PMC2192094.
    279. Ly H, Francone OL, Fielding CJ, Shigenaga JK, Moser AH, Grunfeld C, Feingold K. Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J Lipid Res. 1995 Jun; 36(6):1254-63. PMID: 7666003.
      View in: PubMed
    280. Feingold K, Funk JL, Moser AH, Shigenaga JK, Rapp JH, Grunfeld C. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect Immun. 1995 May; 63(5):2041-6. PMID: 7729918; PMCID: PMC173262.
    281. Ghadially R, Brown BE, Sequeira-Martin SM, Feingold K, Elias PM. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest. 1995 May; 95(5):2281-90. PMID: 7738193; PMCID: PMC295841.
    282. Pratt H, Geva AB, Feingold K, Zeevi YY. Source estimation of auditory brainstem evoked potentials: comparison of 3CLT and dipole localization. Acta Otolaryngol. 1995 May; 115(3):363-6. PMID: 7653255.
      View in: PubMed
    283. Nonogaki K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C, Feingold K. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology. 1995 May; 136(5):2143-9. PMID: 7720663.
      View in: PubMed
    284. Halkier-Sørensen L, Menon GK, Elias PM, Thestrup-Pedersen K, Feingold K. Cutaneous barrier function after cold exposure in hairless mice: a model to demonstrate how cold interferes with barrier homeostasis among workers in the fish-processing industry. Br J Dermatol. 1995 Mar; 132(3):391-401. PMID: 7718455.
      View in: PubMed
    285. Ottey KA, Wood LC, Grunfeld C, Elias PM, Feingold K. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. J Invest Dermatol. 1995 Mar; 104(3):401-4. PMID: 7861009.
      View in: PubMed
    286. Feingold K, Elias PM, Mao-Qiang M, Fartasch M, Zhang SH, Maeda N. Apolipoprotein E deficiency leads to cutaneous foam cell formation in mice. J Invest Dermatol. 1995 Feb; 104(2):246-50. PMID: 7829881.
      View in: PubMed
    287. Holleran WM, Gao WN, Feingold K, Elias PM. Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements. Arch Dermatol Res. 1995; 287(3-4):254-8. PMID: 7598529.
      View in: PubMed
    288. Hurt CM, Hanley K, Williams ML, Feingold K. Cutaneous lipid synthesis during late fetal development in the rat. Arch Dermatol Res. 1995; 287(8):754-60. PMID: 8554388.
      View in: PubMed
    289. Read TE, Grunfeld C, Kumwenda Z, Calhoun MC, Kane JP, Feingold K, Rapp JH. Triglyceride-rich lipoproteins improve survival when given after endotoxin in rats. Surgery. 1995 Jan; 117(1):62-7. PMID: 7809838.
      View in: PubMed
    290. Nonogaki K, Moser AH, Feingold K, Grunfeld C. Alpha-adrenergic receptors mediate the hypertriglyceridemia induced by endotoxin, but not tumor necrosis factor, in rats. Endocrinology. 1994 Dec; 135(6):2644-50. PMID: 7988454.
      View in: PubMed
    291. Staprãns I, Rapp JH, Pan XM, Kim KY, Feingold K. Oxidized lipids in the diet are a source of oxidized lipid in chylomicrons of human serum. Arterioscler Thromb. 1994 Dec; 14(12):1900-5. PMID: 7981177.
      View in: PubMed
    292. Wood LC, Elias PM, Sequeira-Martin SM, Grunfeld C, Feingold K. Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol. 1994 Dec; 103(6):834-8. PMID: 7798624.
      View in: PubMed
    293. Feingold K, Marshall M, Gulli R, Moser AH, Grunfeld C. Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler Thromb. 1994 Nov; 14(11):1866-72. PMID: 7947614.
      View in: PubMed
    294. Feingold K, Siegler EL, Wu B, Stevenson C, Kirk K, Jedrziewski MK. Methicillin-resistant Staphylococcus aureus colonization in a new nursing home. Aging (Milano). 1994 Oct; 6(5):368-71. PMID: 7893783.
      View in: PubMed
    295. Doerrler W, Feingold K, Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine. 1994 Sep; 6(5):478-84. PMID: 7827285.
      View in: PubMed
    296. Hardardóttir I, Kunitake ST, Moser AH, Doerrler WT, Rapp JH, Grünfeld C, Feingold K. Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. J Clin Invest. 1994 Sep; 94(3):1304-9. PMID: 8083372; PMCID: PMC295216.
    297. Marshall MK, Doerrler W, Feingold K, Grunfeld C. Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology. 1994 Jul; 135(1):141-7. PMID: 8013346.
      View in: PubMed
    298. Funk JL, Shigenaga JK, Moser AH, Krul EJ, Strewler GJ, Feingold K, Grunfeld C. Cytokine regulation of parathyroid hormone-related protein messenger ribonucleic acid levels in mouse spleen: paradoxical effects of interferon-gamma and interleukin-4. Endocrinology. 1994 Jul; 135(1):351-8. PMID: 7516868.
      View in: PubMed
    299. Hardardóttir I, Moser AH, Memon R, Grünfeld C, Feingold K. Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res. 1994 Jun; 13(3):161-6. PMID: 7948424.
      View in: PubMed
    300. Hardardóttir I, Grünfeld C, Feingold K. Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol. 1994 Jun; 5(3):207-15. PMID: 7952915.
      View in: PubMed
    301. Lee SH, Elias PM, Feingold K, Mauro T. A role for ions in barrier recovery after acute perturbation. J Invest Dermatol. 1994 Jun; 102(6):976-9. PMID: 8006464.
      View in: PubMed
    302. Menon GK, Price LF, Bommannan B, Elias PM, Feingold K. Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion. J Invest Dermatol. 1994 May; 102(5):789-95. PMID: 8176264.
      View in: PubMed
    303. Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold K, Elias PM. Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res. 1994 May; 35(5):905-12. PMID: 8071612.
      View in: PubMed
    304. Wu-Pong S, Elias PM, Feingold K. Influence of altered serum cholesterol levels and fasting on cutaneous cholesterol synthesis. J Invest Dermatol. 1994 May; 102(5):799-802. PMID: 8176266.
      View in: PubMed
    305. Wood LC, Feingold K, Sequeira-Martin SM, Elias PM, Grunfeld C. Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels. Exp Dermatol. 1994 Apr; 3(2):56-60. PMID: 7921651.
      View in: PubMed
    306. Feingold K, Wilson DE, Wood LC, Kwong LK, Moser AH, Grunfeld C. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine. Metabolism. 1994 Apr; 43(4):450-4. PMID: 8159102.
      View in: PubMed
    307. Memon RA, Grunfeld C, Moser AH, Feingold K. Fatty acid synthesis in obese insulin resistant diabetic mice. Horm Metab Res. 1994 Feb; 26(2):85-7. PMID: 8200619.
      View in: PubMed
    308. Menon GK, Elias PM, Feingold K. Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient. Br J Dermatol. 1994 Feb; 130(2):139-47. PMID: 8123567.
      View in: PubMed
    309. Tsai JC, Feingold K, Crumrine D, Wood LC, Grunfeld C, Elias PM. Permeability barrier disruption alters the localization and expression of TNF alpha/protein in the epidermis. Arch Dermatol Res. 1994; 286(5):242-8. PMID: 8060154.
      View in: PubMed
    310. Jackson SM, Mao-Qiang M, Elias PM, Feingold K. Role of exogenous oxygen in cutaneous barrier repair. Skin Pharmacol. 1994; 7(6):316-9. PMID: 7946373.
      View in: PubMed
    311. Read TE, Harris HW, Grunfeld C, Feingold K, Kane JP, Rapp JH. The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J. 1993 Dec; 14 Suppl K:125-9. PMID: 8131781.
      View in: PubMed
    312. Feingold K, Hardardottir I, Memon R, Krul EJ, Moser AH, Taylor JM, Grunfeld C. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res. 1993 Dec; 34(12):2147-58. PMID: 8301233.
      View in: PubMed
    313. Funk JL, Krul EJ, Moser AH, Shigenaga JK, Strewler GJ, Grunfeld C, Feingold K. Endotoxin increases parathyroid hormone-related protein mRNA levels in mouse spleen. Mediation by tumor necrosis factor. J Clin Invest. 1993 Nov; 92(5):2546-52. PMID: 8227368; PMCID: PMC288441.
    314. Synder SM, Terdiman JF, Caan B, Feingold K, Hubl ST, Smith RS, Young SG. Relationship of apolipoprotein E phenotypes to hypocholesterolemia. Am J Med. 1993 Nov; 95(5):480-8. PMID: 8238064.
      View in: PubMed
    315. Grunfeld C, Pang M, Doerrler W, Jensen P, Shimizu L, Feingold K, Cavalieri RR. Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism. 1993 Oct; 42(10):1270-6. PMID: 8412739.
      View in: PubMed
    316. Grunfeld C, Feingold K. Body weight as essential data in the management of patients with human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr. 1993 Sep; 58(3):317-8. PMID: 8237839.
      View in: PubMed
    317. Mao-Qiang M, Feingold K, Elias PM. Inhibition of cholesterol and sphingolipid synthesis causes paradoxical effects on permeability barrier homeostasis. J Invest Dermatol. 1993 Aug; 101(2):185-90. PMID: 8345219.
      View in: PubMed
    318. Staprans I, Rapp JH, Pan XM, Feingold K. The effect of oxidized lipids in the diet on serum lipoprotein peroxides in control and diabetic rats. J Clin Invest. 1993 Aug; 92(2):638-43. PMID: 8349802; PMCID: PMC294896.
    319. Read TE, Harris HW, Grunfeld C, Feingold K, Calhoun MC, Kane JP, Rapp JH. Chylomicrons enhance endotoxin excretion in bile. Infect Immun. 1993 Aug; 61(8):3496-502. PMID: 8335381; PMCID: PMC281028.
    320. Mao-Qiang M, Elias PM, Feingold K. Fatty acids are required for epidermal permeability barrier function. J Clin Invest. 1993 Aug; 92(2):791-8. PMID: 8102380; PMCID: PMC294916.
    321. Joles JA, Feingold K, Van Tol A, Cohen LH, Sun X, Jones H, Davies RW, Kaysen GA. Extrahepatic lipogenesis contributes to hyperlipidemia in the analbuminemic rat. Am J Physiol. 1993 Jul; 265(1 Pt 2):F70-6. PMID: 8342616.
      View in: PubMed
    322. Aszterbaum M, Feingold K, Menon GK, Williams ML. Glucocorticoids accelerate fetal maturation of the epidermal permeability barrier in the rat. J Clin Invest. 1993 Jun; 91(6):2703-8. PMID: 8514877; PMCID: PMC443334.
    323. Man MQ, Feingold K, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol. 1993 Jun; 129(6):728-38. PMID: 8507075.
      View in: PubMed
    324. Feingold K, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab. 1993 Jun; 76(6):1423-7. PMID: 8501146.
      View in: PubMed
    325. Proksch E, Holleran WM, Menon GK, Elias PM, Feingold K. Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol. 1993 May; 128(5):473-82. PMID: 8504036.
      View in: PubMed
    326. Memon RA, Grunfeld C, Moser AH, Feingold K. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology. 1993 May; 132(5):2246-53. PMID: 8477669.
      View in: PubMed
    327. Williams ML, Aszterbaum M, Menon GK, Moser AH, Feingold K, Hoath SB. Preservation of permeability barrier ontogenesis in the intrauterine growth-retarded fetal rat. Pediatr Res. 1993 Apr; 33(4 Pt 1):418-24. PMID: 8479825.
      View in: PubMed
    328. Holleran WM, Takagi Y, Menon GK, Legler G, Feingold K, Elias PM. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest. 1993 Apr; 91(4):1656-64. PMID: 8473508; PMCID: PMC288144.
    329. Harris HW, Grunfeld C, Feingold K, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF, Rapp JH. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest. 1993 Mar; 91(3):1028-34. PMID: 8450032; PMCID: PMC288056.
    330. Jackson SM, Williams ML, Feingold K, Elias PM. Pathobiology of the stratum corneum. West J Med. 1993 Mar; 158(3):279-85. PMID: 8460510; PMCID: PMC1311754.
    331. Funk JL, Feingold K, Moser AH, Grunfeld C. Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis. 1993 Jan 4; 98(1):67-82. PMID: 8457252.
      View in: PubMed
    332. Feingold K, Staprans I, Memon RA, Moser AH, Shigenaga JK, Doerrler W, Dinarello CA, Grunfeld C. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res. 1992 Dec; 33(12):1765-76. PMID: 1479286.
      View in: PubMed
    333. Feingold K, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb. 1992 Dec; 12(12):1496-502. PMID: 1450181.
      View in: PubMed
    334. Menon GK, Elias PM, Lee SH, Feingold K. Localization of calcium in murine epidermis following disruption and repair of the permeability barrier. Cell Tissue Res. 1992 Dec; 270(3):503-12. PMID: 1486603.
      View in: PubMed
    335. Memon RA, Feingold K, Moser AH, Doerrler W, Grunfeld C. In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis. Endocrinology. 1992 Oct; 131(4):1695-702. PMID: 1396316.
      View in: PubMed
    336. Feingold K, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes. 1992 Oct; 41 Suppl 2:97-101. PMID: 1526345.
      View in: PubMed
    337. Jackson SM, Wood LC, Lauer S, Taylor JM, Cooper AD, Elias PM, Feingold K. Effect of cutaneous permeability barrier disruption on HMG-CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice. J Lipid Res. 1992 Sep; 33(9):1307-14. PMID: 1402399.
      View in: PubMed
    338. Memon RA, Feingold K, Moser AH, Doerrler W, Adi S, Dinarello CA, Grunfeld C. Differential effects of interleukin-1 and tumor necrosis factor on ketogenesis. Am J Physiol. 1992 Aug; 263(2 Pt 1):E301-9. PMID: 1514611.
      View in: PubMed
    339. Proksch E, Feingold K, Elias PM. Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis. J Invest Dermatol. 1992 Aug; 99(2):216-20. PMID: 1629633.
      View in: PubMed
    340. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold K. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992 Aug; 90(2):482-7. PMID: 1644919; PMCID: PMC443124.
    341. Grunfeld C, Feingold K. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 1992 Jul 30; 327(5):329-37. PMID: 1620172.
      View in: PubMed
    342. Hardardóttir I, Doerrler W, Feingold K, Grünfeld C. Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism. Biochem Biophys Res Commun. 1992 Jul 15; 186(1):237-43. PMID: 1632769.
      View in: PubMed
    343. Grunfeld C, Feingold K. Tumor necrosis factor, interleukin, and interferon induced changes in lipid metabolism as part of host defense. Proc Soc Exp Biol Med. 1992 Jun; 200(2):224-7. PMID: 1374564.
      View in: PubMed
    344. Elias PM, Feingold K. Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology. Semin Dermatol. 1992 Jun; 11(2):176-82. PMID: 1498022.
      View in: PubMed
    345. Adi S, Pollock AS, Shigenaga JK, Moser AH, Feingold K, Grunfeld C. Role for monokines in the metabolic effects of endotoxin. Interferon-gamma restores responsiveness of C3H/HeJ mice in vivo. J Clin Invest. 1992 May; 89(5):1603-9. PMID: 1569198; PMCID: PMC443035.
    346. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold K. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1992 May; 74(5):1045-52. PMID: 1373735.
      View in: PubMed
    347. Aszterbaum M, Menon GK, Feingold K, Williams ML. Ontogeny of the epidermal barrier to water loss in the rat: correlation of function with stratum corneum structure and lipid content. Pediatr Res. 1992 Apr; 31(4 Pt 1):308-17. PMID: 1570196.
      View in: PubMed
    348. Menon GK, Feingold K, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol. 1992 Mar; 98(3):279-89. PMID: 1545137.
      View in: PubMed
    349. Staprans I, Pan XM, Rapp JH, Feingold K. Chylomicron and chylomicron remnant metabolism in STZ-induced diabetic rats. Diabetes. 1992 Mar; 41(3):325-33. PMID: 1551492.
      View in: PubMed
    350. Grunfeld C, Feingold K. The role of the cytokines, interferon alpha and tumor necrosis factor in the hypertriglyceridemia and wasting of AIDs. J Nutr. 1992 Mar; 122(3 Suppl):749-53. PMID: 1542042.
      View in: PubMed
    351. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold K. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr. 1992 Feb; 55(2):455-60. PMID: 1734684.
      View in: PubMed
    352. Menon GK, Feingold K, Mao-Qiang M, Schaude M, Elias PM. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis. J Invest Dermatol. 1992 Feb; 98(2):209-19. PMID: 1732385.
      View in: PubMed
    353. Lee SH, Elias PM, Proksch E, Menon GK, Mao-Quiang M, Feingold K. Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest. 1992 Feb; 89(2):530-8. PMID: 1737844; PMCID: PMC442884.
    354. Grunfeld C, Memon RA, Rapp JH, Feingold K. Regulation of hepatic lipid metabolism by cytokines that induce the acute phase response. Folia Histochem Cytobiol. 1992; 30(4):201-2. PMID: 1303901.
      View in: PubMed
    355. Feingold K, Doerrler W, Dinarello CA, Fiers W, Grunfeld C. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology. 1992 Jan; 130(1):10-6. PMID: 1370149.
      View in: PubMed
    356. Kwong LK, Feingold K, Peric-Golia L, Le T, Karkas JD, Alberts AW, Wilson DE. Intestinal and hepatic cholesterogenesis in hypercholesterolemic dyslipidemia of experimental diabetes in dogs. Diabetes. 1991 Dec; 40(12):1630-9. PMID: 1756903.
      View in: PubMed
    357. Grunfeld C, Feingold K. Tumor necrosis factor, cytokines, and the hyperlipidemia of infection. Trends Endocrinol Metab. 1991 Nov-Dec; 2(6):213-9. PMID: 18411185.
      View in: PubMed
    358. Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold K. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest. 1991 Oct; 88(4):1338-45. PMID: 1918384; PMCID: PMC295604.
    359. Grunfeld C, Dinarello CA, Feingold K. Tumor necrosis factor-alpha, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells. Metabolism. 1991 Sep; 40(9):894-8. PMID: 1654497.
      View in: PubMed
    360. Holleran WM, Feingold K, Man MQ, Gao WN, Lee JM, Elias PM. Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res. 1991 Jul; 32(7):1151-8. PMID: 1940639.
      View in: PubMed
    361. Grunfeld C, Soued M, Adi S, Moser AH, Fiers W, Dinarello CA, Feingold K. Interleukin 4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin 1, and interleukin 6 but not by interferon-alpha. Cancer Res. 1991 Jun 1; 51(11):2803-7. PMID: 2032220.
      View in: PubMed
    362. Feingold K, Soued M, Adi S, Staprans I, Neese R, Shigenaga J, Doerrler W, Moser A, Dinarello CA, Grunfeld C. Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor. Arterioscler Thromb. 1991 May-Jun; 11(3):495-500. PMID: 2029492.
      View in: PubMed
    363. Proksch E, Feingold K, Man MQ, Elias PM. Barrier function regulates epidermal DNA synthesis. J Clin Invest. 1991 May; 87(5):1668-73. PMID: 2022737; PMCID: PMC295261.
    364. Proksch E, Elias PM, Feingold K. Localization and regulation of epidermal 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by barrier requirements. Biochim Biophys Acta. 1991 Apr 24; 1083(1):71-9. PMID: 2031940.
      View in: PubMed
    365. Feingold K, Barker ME, Jones AL, Grunfeld C. Localization of tumor necrosis factor-stimulated DNA synthesis in the liver. Hepatology. 1991 Apr; 13(4):773-9. PMID: 2010173.
      View in: PubMed
    366. Feingold K. Hypoglycemia--a major risk of insulin therapy. West J Med. 1991 Apr; 154(4):469-71. PMID: 1877198; PMCID: PMC1002807.
    367. Feingold K, Man MQ, Proksch E, Menon GK, Brown BE, Elias PM. The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia. J Invest Dermatol. 1991 Feb; 96(2):201-9. PMID: 1991980.
      View in: PubMed
    368. Grunfeld C, Kotler DP, Shigenaga JK, Doerrler W, Tierney A, Wang J, Pierson RN, Feingold K. Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med. 1991 Feb; 90(2):154-62. PMID: 1996584.
      View in: PubMed
    369. Feingold K. The regulation and role of epidermal lipid synthesis. Adv Lipid Res. 1991; 24:57-82. PMID: 1763718.
      View in: PubMed
    370. Feingold K. The regulation of epidermal lipid synthesis by permeability barrier requirements. Crit Rev Ther Drug Carrier Syst. 1991; 8(3):193-210. PMID: 1954650.
      View in: PubMed
    371. Grunfeld C, Feingold K. The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy. 1991; 3(2):143-58. PMID: 2054255.
      View in: PubMed
    372. Feingold K, Soued M, Adi S, Staprans I, Shigenaga J, Doerrler W, Moser A, Grunfeld C. Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats. Diabetes. 1990 Dec; 39(12):1569-74. PMID: 1978829.
      View in: PubMed
    373. Feingold K, Man MQ, Menon GK, Cho SS, Brown BE, Elias PM. Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest. 1990 Nov; 86(5):1738-45. PMID: 2243142; PMCID: PMC296927.
    374. Feingold K, Moser A, Adi S, Soued M, Grunfeld C. Small intestinal fatty acid synthesis is increased in diabetic rats. Endocrinology. 1990 Nov; 127(5):2247-52. PMID: 2226313.
      View in: PubMed
    375. Harris HW, Grunfeld C, Feingold K, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest. 1990 Sep; 86(3):696-702. PMID: 2394827; PMCID: PMC296783.
    376. Krauss RM, Grunfeld C, Doerrler WT, Feingold K. Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition. Endocrinology. 1990 Sep; 127(3):1016-21. PMID: 2387245.
      View in: PubMed
    377. Feingold K, Adi S, Staprans I, Moser AH, Neese R, Verdier JA, Doerrler W, Grunfeld C. Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. Am J Physiol. 1990 Aug; 259(2 Pt 1):E177-84. PMID: 2382712.
      View in: PubMed
    378. Grunfeld C, Adi S, Soued M, Moser A, Fiers W, Feingold K. Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6. Cancer Res. 1990 Jul 15; 50(14):4233-8. PMID: 2364381.
      View in: PubMed
    379. Staprans I, Rapp JH, Pan XM, Ong DL, Feingold K. Testosterone regulates metabolism of plasma chylomicrons in rats. Arteriosclerosis. 1990 Jul-Aug; 10(4):591-6. PMID: 2369368.
      View in: PubMed
    380. Grunfeld C, Soued M, Adi S, Moser AH, Dinarello CA, Feingold K. Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha. Endocrinology. 1990 Jul; 127(1):46-54. PMID: 1972922.
      View in: PubMed
    381. Feingold K, Soued M, Serio MK, Adi S, Moser AH, Grunfeld C. The effect of diet on tumor necrosis factor stimulation of hepatic lipogenesis. Metabolism. 1990 Jun; 39(6):623-32. PMID: 2352479.
      View in: PubMed
    382. Proksch E, Elias PM, Feingold K. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J Clin Invest. 1990 Mar; 85(3):874-82. PMID: 2312730; PMCID: PMC296505.
    383. Pratt H, Bleich N, Feingold K. Three-channel Lissajous' trajectories of auditory brainstem evoked potentials: contribution of fast and slow components to planar segment formation. Hear Res. 1990 Jan; 43(2-3):159-70. PMID: 2312411.
      View in: PubMed
    384. Searle GL, Feingold K, Hsu FS, Clark OH, Gertz EW, Stanley WC. Inhibition of endogenous lactate turnover with lactate infusion in humans. Metabolism. 1989 Nov; 38(11):1120-3. PMID: 2811680.
      View in: PubMed
    385. Feingold K, Browner WS, Siperstein MD. Prospective studies of muscle capillary basement membrane width in prediabetics. J Clin Endocrinol Metab. 1989 Oct; 69(4):784-9. PMID: 2778035.
      View in: PubMed
    386. Feingold K, Soued M, Serio MK, Moser AH, Dinarello CA, Grunfeld C. Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology. 1989 Jul; 125(1):267-74. PMID: 2661207.
      View in: PubMed
    387. Grunfeld C, Wilking H, Neese R, Gavin LA, Moser AH, Gulli R, Serio MK, Feingold K. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res. 1989 May 15; 49(10):2554-60. PMID: 2713842.
      View in: PubMed
    388. Feingold K, Serio MK, Adi S, Moser AH, Grunfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology. 1989 May; 124(5):2336-42. PMID: 2707158.
      View in: PubMed
    389. Feingold K, Soued M, Staprans I, Gavin LA, Donahue ME, Huang BJ, Moser AH, Gulli R, Grunfeld C. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. J Clin Invest. 1989 Apr; 83(4):1116-21. PMID: 2703526; PMCID: PMC303797.
    390. Grunfeld C, Gulli R, Moser AH, Gavin LA, Feingold K. Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res. 1989 Apr; 30(4):579-85. PMID: 2754338.
      View in: PubMed
    391. Feingold K, Castro GR, Ishikawa Y, Fielding PE, Fielding CJ. Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia. J Clin Invest. 1989 Mar; 83(3):796-802. PMID: 2921322; PMCID: PMC303750.
    392. Grubauer G, Elias PM, Feingold K. Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res. 1989 Mar; 30(3):323-33. PMID: 2723540.
      View in: PubMed
    393. Feingold K. Importance of small intestine in diabetic hypercholesterolemia. Diabetes. 1989 Feb; 38(2):141-5. PMID: 2644136.
      View in: PubMed
    394. Feingold K, Zeng QH, Soued M, Siperstein A, Serio MK, Clark OH, Moser AH. Total gastrectomy and small intestinal cholesterol synthesis in diabetic rats. Diabetes. 1989 Feb; 38(2):219-24. PMID: 2914624.
      View in: PubMed
    395. Feingold K, Zeng QH, Soued M, Moser AH. Cholesterol synthesis in bypassed segments of the small intestine in hyperphagic rats. Gastroenterology. 1989 Feb; 96(2 Pt 1):307-13. PMID: 2521331.
      View in: PubMed
    396. Grubauer G, Feingold K, Harris RM, Elias PM. Lipid content and lipid type as determinants of the epidermal permeability barrier. J Lipid Res. 1989 Jan; 30(1):89-96. PMID: 2918253.
      View in: PubMed
    397. Grunfeld C, Verdier JA, Neese R, Moser AH, Feingold K. Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis in vivo. J Lipid Res. 1988 Oct; 29(10):1327-35. PMID: 2906959.
      View in: PubMed
    398. Feingold K, Elias PM. Endocrine-skin interactions. Cutaneous manifestations of adrenal disease, pheochromocytomas, carcinoid syndrome, sex hormone excess and deficiency, polyglandular autoimmune syndromes, multiple endocrine neoplasia syndromes, and other miscellaneous disorders. J Am Acad Dermatol. 1988 Jul; 19(1 Pt 1):1-20. PMID: 2900255.
      View in: PubMed
    399. Feingold K, Soued M, Grunfeld C. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Commun. 1988 Jun 16; 153(2):576-82. PMID: 3132913.
      View in: PubMed
    400. Erickson SK, Cooper AD, Barnard GF, Havel CM, Watson JA, Feingold K, Moser AH, Hughes-Fulford M, Siperstein MD. Regulation of cholesterol metabolism in a slow-growing hepatoma in vivo. Biochim Biophys Acta. 1988 May 22; 960(2):131-8. PMID: 2835108.
      View in: PubMed
    401. Monger DJ, Williams ML, Feingold K, Brown BE, Elias PM. Localization of sites of lipid biosynthesis in mammalian epidermis. J Lipid Res. 1988 May; 29(5):603-12. PMID: 3411237.
      View in: PubMed
    402. Elias PM, Feingold K. Lipid-related barriers and gradients in the epidermis. Ann N Y Acad Sci. 1988; 548:4-13. PMID: 3073705.
      View in: PubMed
    403. Feingold K, Elias PM. Endocrine-skin interactions. Cutaneous manifestations of pituitary disease, thyroid disease, calcium disorders, and diabetes. J Am Acad Dermatol. 1987 Dec; 17(6):921-40. PMID: 3323273.
      View in: PubMed
    404. Williams ML, Feingold K, Grubauer G, Elias PM. Ichthyosis induced by cholesterol-lowering drugs. Implications for epidermal cholesterol homeostasis. Arch Dermatol. 1987 Nov; 123(11):1535-8. PMID: 3674913.
      View in: PubMed
    405. Feingold K, Moser AH. Effect of hypocholesterolemia on cholesterol synthesis in small intestine of diabetic rats. Diabetes. 1987 Nov; 36(11):1223-9. PMID: 3666315.
      View in: PubMed
    406. Feingold K, Williams ML, Pillai S, Menon GK, Halloran BP, Bikle DD, Elias PM. The effect of vitamin D status on cutaneous sterologenesis in vivo and in vitro. Biochim Biophys Acta. 1987 Sep 14; 930(2):193-200. PMID: 3040120.
      View in: PubMed
    407. Feingold K, Moser AH. Localization of cholesterol synthesis along villus-crypt axis in diabetic rats. Am J Physiol. 1987 Sep; 253(3 Pt 1):G336-44. PMID: 2957925.
      View in: PubMed
    408. Williams ML, Rutherford SL, Feingold K. Effects of cholesterol sulfate on lipid metabolism in cultured human keratinocytes and fibroblasts. J Lipid Res. 1987 Aug; 28(8):955-67. PMID: 2444666.
      View in: PubMed
    409. Feingold K, Lear SR, Felts JM. The disappearance from the circulation of chylomicrons obtained from control and diabetic rats. Endocrinology. 1987 Aug; 121(2):475-80. PMID: 3595526.
      View in: PubMed
    410. Feingold K, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest. 1987 Jul; 80(1):184-90. PMID: 3597772; PMCID: PMC442217.
    411. Grubauer G, Feingold K, Elias PM. Relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res. 1987 Jun; 28(6):746-52. PMID: 3611976.
      View in: PubMed
    412. Klein RF, Feingold K, Morgan C, Stern WH, Siperstein MD. Relationship of muscle capillary basement membrane thickness and diabetic retinopathy. Diabetes Care. 1987 Mar-Apr; 10(2):195-9. PMID: 3582080.
      View in: PubMed
    413. Feingold K, Brown BE, Lear SR, Moser AH, Elias PM. Effect of essential fatty acid deficiency on cutaneous sterol synthesis. J Invest Dermatol. 1986 Nov; 87(5):588-91. PMID: 3772153.
      View in: PubMed
    414. Golper TA, Feingold K, Fulford MH, Siperstein MD. The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat. J Lipid Res. 1986 Oct; 27(10):1044-51. PMID: 3794548.
      View in: PubMed
    415. Feingold K, Zsigmond G, Lear SR, Moser AH. Effect of food intake on intestinal cholesterol synthesis in rats. Am J Physiol. 1986 Sep; 251(3 Pt 1):G362-9. PMID: 3752250.
      View in: PubMed
    416. Feingold K, Moser AH. The effect of substrates and competitive inhibitors on the phosphatase-dependent activation of hepatic hydroxymethylglutaryl CoA reductase. Arch Biochem Biophys. 1986 Aug 15; 249(1):46-52. PMID: 3017222.
      View in: PubMed
    417. Feingold K, Lee TH, Chung MY, Siperstein MD. Muscle capillary basement membrane width in patients with vacor-induced diabetes mellitus. J Clin Invest. 1986 Jul; 78(1):102-7. PMID: 3722372; PMCID: PMC329537.
    418. Hughes-Fulford M, Feingold K, Searle GL, Wu J, Siperstein MD, Schoenfeld PY, Kaysen G. Role of the kidneys in the metabolism of circulating mevalonate in humans. J Clin Endocrinol Metab. 1986 Jun; 62(6):1227-31. PMID: 3084536.
      View in: PubMed
    419. Cohen FE, Sater B, Feingold K. Potential danger of extending SMBG techniques to hospital wards. Diabetes Care. 1986 May-Jun; 9(3):320-2. PMID: 3732005.
      View in: PubMed
    420. Feingold K, Siperstein MD. Diabetic vascular disease. Adv Intern Med. 1986; 31:309-40. PMID: 3511622.
      View in: PubMed
    421. Feingold K, Zsigmond G, Hughes-Fulford M, Lear SR, Moser AH. The effect of diabetes mellitus on the lymphatic transport of intestinal sterols. Metabolism. 1985 Dec; 34(12):1105-9. PMID: 4069009.
      View in: PubMed
    422. Feingold K, Moser AH. Effect of glucose or fructose feeding on cholesterol synthesis in diabetic animals. Am J Physiol. 1985 Nov; 249(5 Pt 1):G634-41. PMID: 2932918.
      View in: PubMed
    423. Feingold K, Moser AH. Effect of lactation on cholesterol synthesis in rats. Am J Physiol. 1985 Aug; 249(2 Pt 1):G203-8. PMID: 4025547.
      View in: PubMed
    424. Menon GK, Feingold K, Moser AH, Brown BE, Elias PM. De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements. J Lipid Res. 1985 Apr; 26(4):418-27. PMID: 4009060.
      View in: PubMed
    425. Feingold K, Lorenz TJ. Acromegaly with 'normal' growth hormone levels. West J Med. 1985 Jan; 142(1):95-7. PMID: 3976225; PMCID: PMC1305950.
    426. Feingold K, Moser AH. Localization of cholesterol synthesis in the small intestine of diabetic rats. Am J Physiol. 1984 Nov; 247(5 Pt 1):G494-501. PMID: 6496740.
      View in: PubMed
    427. Trentalance A, Leoni S, Mangiantini MT, Spagnuolo S, Feingold K, Hughes-Fulford M, Siperstein M, Cooper AD, Erickson SK. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol synthesis and esterification during the first cell cycle of liver regeneration. Biochim Biophys Acta. 1984 Jun 6; 794(1):142-51. PMID: 6733123.
      View in: PubMed
    428. Feingold K, Lear SR, Moser AH. De novo cholesterol synthesis in three different animal models of diabetes. Diabetologia. 1984 Mar; 26(3):234-9. PMID: 6714541.
      View in: PubMed
    429. Feingold K, Wiley MH, Moser AH, Siperstein MD. Altered activation state of hydroxymethylglutaryl-coenzyme A reductase in liver tumors. Arch Biochem Biophys. 1983 Oct 1; 226(1):231-41. PMID: 6605722.
      View in: PubMed
    430. Feingold K, Brown BE, Lear SR, Moser AH, Elias PM. Localization of de novo sterologenesis in mammalian skin. J Invest Dermatol. 1983 Oct; 81(4):365-9. PMID: 6619567.
      View in: PubMed
    431. Feingold K, Sater B, Engle B. Iodine-induced artifacts in home blood glucose measurements. Diabetes Care. 1983 May-Jun; 6(3):317-8. PMID: 6872816.
      View in: PubMed
    432. Feingold K, Wiley MH, Moser AH, Lear SR. The effect of cholesterol feeding and alterations in bile acid homeostasis on de novo sterologenesis in diabetic rats. Diabetes. 1983 Apr; 32(4):368-76. PMID: 6832491.
      View in: PubMed
    433. Feingold K, Wiley MH, MacRae G, Kaysen G, Schoenfeld PY, Siperstein MD. The effect of uremia on circulating mevalonate metabolism in rats. Metabolism. 1983 Mar; 32(3):215-23. PMID: 6827993.
      View in: PubMed
    434. Feingold K, Wiley MH, Moser AH, Lear SR, Siperstein MD. Activation of HMG-CoA reductase by microsomal phosphatase. J Lipid Res. 1983 Mar; 24(3):290-6. PMID: 6302189.
      View in: PubMed
    435. Feingold K, Siperstein MD. Normalization of fasting blood glucose levels in insulin-requiring diabetes: the role of ethanol abstention. Diabetes Care. 1983 Mar-Apr; 6(2):186-8. PMID: 6343024.
      View in: PubMed
    436. Feingold K, Wiley T, Moser AH, Lear SR, Wiley MH. De novo cholesterogenesis in pregnancy. J Lab Clin Med. 1983 Feb; 101(2):256-63. PMID: 6822762.
      View in: PubMed
    437. Wiley MH, Feingold K, Grunfeld C, Quesney-Huneeus V, Wu JM. Evidence for cAMP-independent inhibition of S-phase DNA synthesis by prostaglandins. J Biol Chem. 1983 Jan 10; 258(1):491-6. PMID: 6294110.
      View in: PubMed
    438. Feingold K, Wiley MH, MacRae G, Lear S, Moser AH, Zsigmond G, Siperstein MD. De novo sterologenesis in the intact rat. Metabolism. 1983 Jan; 32(1):75-81. PMID: 6848899.
      View in: PubMed
    439. Feingold K, MacRae G, Moser AH, Wu J, Siperstein MD, Wiley MH. Differences in de novo cholesterol synthesis between the intact male and female rat. Endocrinology. 1983 Jan; 112(1):96-103. PMID: 6847837.
      View in: PubMed
    440. Feingold K, Wiley MH, Moser AH, Lau DT, Lear SR, Siperstein MD. De novo sterologenesis in intact primates. J Lab Clin Med. 1982 Sep; 100(3):405-10. PMID: 6809874.
      View in: PubMed
    441. Feingold K, Wiley MH, Moser AH, Siperstein MD. Inhibition of the dephosphorylation of HMG CoA reductase by its substrates. Biochem Biophys Res Commun. 1982 Aug 31; 107(4):1376-83. PMID: 7138544.
      View in: PubMed
    442. Feingold K, Wiley MH, MacRae G, Moser AH, Lear SR, Siperstein MD. The effect of diabetes mellitus on sterol synthesis in the intact rat. Diabetes. 1982 May; 31(5 Pt 1):388-95. PMID: 7152132.
      View in: PubMed
    443. Wiley MH, Feingold K, Howton MM, Siperstein MD. The effect of diabetes on mevalonate metabolism in the rat. Diabetologia. 1982 Feb; 22(2):118-21. PMID: 6460657.
      View in: PubMed
    444. Feingold K, Wiley MH, MacRae G, Siperstein MD. The effect of decreased plasma cholesterol concentration on circulatinga mevalonate metabolism in rats. J Lipid Res. 1981 Aug; 22(6):990-7. PMID: 7276756.
      View in: PubMed
    445. Feingold K, Wiley MH, MacRae G, Siperstein MD. Influence of thyroid hormone status on mevalonate metabolism in rats. J Clin Invest. 1980 Oct; 66(4):646-54. PMID: 7419712; PMCID: PMC371637.
    446. Feingold K, Wiley MH, MacRae G, Siperstein MD. Mevalonate metabolism in pregnant rats. Metabolism. 1980 Sep; 29(9):285-91. PMID: 6774201.
      View in: PubMed
    447. Feingold K, Wiley MH, Searle GL, Machida BK, Siperstein MD. Sex difference in human mevalonate metabolism. J Clin Invest. 1980 Aug; 66(2):361-6. PMID: 7400320; PMCID: PMC371718.
    448. Feingold K. The danger of a changing renal threshold for glucose. Diabetes Care. 1980 Jul-Aug; 3(4):570-1. PMID: 7460733.
      View in: PubMed
    449. Yamamoto M, Rapoport B, Clark OH, Feingold K. Studies on the pathophysiological role of thyroidal prostaglandin E (PGE) in Graves' disease. Horm Metab Res. 1980; 12(6):256-60. PMID: 6893314.
      View in: PubMed
    450. Feingold K, Goldfine ID, Weinstein PR. Acromegaly with normal growth-hormone levels and pituitary histology. Case report. J Neurosurg. 1979 Apr; 50(4):503-7. PMID: 106097.
      View in: PubMed
    451. Siperstein MD, Feingold K, Bennet PH. Hyperglycaemia and diabetic microangiopathy. Diabetologia. 1978 Nov; 15(5):365-7. PMID: 738548.
      View in: PubMed
    Kenneth's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP